CA2156729A1 - New 4-aminopyridines, processes for their production as well as pharmaceutical agents containing these compounds - Google Patents
New 4-aminopyridines, processes for their production as well as pharmaceutical agents containing these compoundsInfo
- Publication number
- CA2156729A1 CA2156729A1 CA002156729A CA2156729A CA2156729A1 CA 2156729 A1 CA2156729 A1 CA 2156729A1 CA 002156729 A CA002156729 A CA 002156729A CA 2156729 A CA2156729 A CA 2156729A CA 2156729 A1 CA2156729 A1 CA 2156729A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- methyl
- phenyl
- compound
- pyridin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 321
- 150000003928 4-aminopyridines Chemical class 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 14
- 230000008569 process Effects 0.000 title claims abstract description 10
- 239000008177 pharmaceutical agent Substances 0.000 title claims abstract description 9
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 41
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 33
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 23
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 17
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 16
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 16
- 150000002367 halogens Chemical class 0.000 claims abstract description 16
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 14
- 150000003839 salts Chemical class 0.000 claims abstract description 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 11
- 239000001257 hydrogen Substances 0.000 claims abstract description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 125000005843 halogen group Chemical group 0.000 claims abstract description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 8
- 125000004430 oxygen atom Chemical group O* 0.000 claims abstract description 8
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 7
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 7
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims abstract description 5
- 150000001412 amines Chemical class 0.000 claims abstract description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 5
- 125000001188 haloalkyl group Chemical group 0.000 claims abstract description 5
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 5
- 239000001301 oxygen Substances 0.000 claims abstract description 5
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 5
- 239000012453 solvate Substances 0.000 claims abstract description 5
- 239000005864 Sulphur Substances 0.000 claims abstract description 4
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 4
- 150000004677 hydrates Chemical class 0.000 claims abstract description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 3
- -1 amino, carboxyl Chemical group 0.000 claims description 109
- 239000000460 chlorine Substances 0.000 claims description 34
- 125000003118 aryl group Chemical group 0.000 claims description 29
- 125000001072 heteroaryl group Chemical group 0.000 claims description 27
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 19
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 16
- 229960004979 fampridine Drugs 0.000 claims description 16
- NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 claims description 15
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 14
- 229910052801 chlorine Inorganic materials 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 13
- 125000003342 alkenyl group Chemical group 0.000 claims description 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 11
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 10
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 10
- 125000006193 alkinyl group Chemical group 0.000 claims description 10
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 9
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 9
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 9
- 125000003277 amino group Chemical group 0.000 claims description 8
- 125000004966 cyanoalkyl group Chemical group 0.000 claims description 8
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 8
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 7
- 125000003282 alkyl amino group Chemical group 0.000 claims description 7
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 7
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 7
- 239000011737 fluorine Substances 0.000 claims description 7
- 229910052731 fluorine Inorganic materials 0.000 claims description 7
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 claims description 6
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims description 6
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 6
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 claims description 6
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 5
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 5
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 5
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 claims description 5
- 125000004414 alkyl thio group Chemical group 0.000 claims description 5
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 5
- 239000012634 fragment Substances 0.000 claims description 5
- 150000002825 nitriles Chemical class 0.000 claims description 5
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 4
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 4
- 239000004305 biphenyl Substances 0.000 claims description 4
- 235000010290 biphenyl Nutrition 0.000 claims description 4
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 4
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims description 4
- 125000001624 naphthyl group Chemical group 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims description 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 3
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 3
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 3
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 claims description 3
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 claims description 3
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 3
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 3
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 claims description 3
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 3
- 150000003222 pyridines Chemical class 0.000 claims description 3
- 125000004076 pyridyl group Chemical group 0.000 claims description 3
- 125000001544 thienyl group Chemical group 0.000 claims description 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 2
- 208000001435 Thromboembolism Diseases 0.000 claims description 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 2
- 125000003368 amide group Chemical group 0.000 claims description 2
- 125000001691 aryl alkyl amino group Chemical group 0.000 claims description 2
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 2
- 125000002560 nitrile group Chemical group 0.000 claims description 2
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000005133 alkynyloxy group Chemical group 0.000 claims 1
- 125000005225 alkynyloxycarbonyl group Chemical group 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 2
- 125000004122 cyclic group Chemical group 0.000 abstract 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 230
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 92
- 239000002904 solvent Substances 0.000 description 90
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 84
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 81
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 81
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 78
- 229940093499 ethyl acetate Drugs 0.000 description 77
- 235000019439 ethyl acetate Nutrition 0.000 description 76
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 72
- 239000003921 oil Substances 0.000 description 69
- 235000019198 oils Nutrition 0.000 description 69
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 67
- 239000000243 solution Substances 0.000 description 62
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 44
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 42
- 238000006243 chemical reaction Methods 0.000 description 40
- 108090000190 Thrombin Proteins 0.000 description 34
- 229960004072 thrombin Drugs 0.000 description 34
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 31
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 30
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 26
- 229960000583 acetic acid Drugs 0.000 description 24
- 235000011121 sodium hydroxide Nutrition 0.000 description 24
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 21
- 239000012074 organic phase Substances 0.000 description 20
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 19
- 238000010992 reflux Methods 0.000 description 19
- 229960003010 sodium sulfate Drugs 0.000 description 19
- 229910052938 sodium sulfate Inorganic materials 0.000 description 19
- 235000011152 sodium sulphate Nutrition 0.000 description 19
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical compound CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 18
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 18
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 17
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 16
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 16
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 16
- 239000012071 phase Substances 0.000 description 16
- 239000000741 silica gel Substances 0.000 description 16
- 229910002027 silica gel Inorganic materials 0.000 description 16
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 16
- 239000007858 starting material Substances 0.000 description 16
- 235000011149 sulphuric acid Nutrition 0.000 description 16
- 238000005259 measurement Methods 0.000 description 15
- 230000002829 reductive effect Effects 0.000 description 15
- 239000001117 sulphuric acid Substances 0.000 description 15
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 14
- 125000004432 carbon atom Chemical group C* 0.000 description 14
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 13
- 229910021529 ammonia Inorganic materials 0.000 description 13
- 239000000843 powder Substances 0.000 description 13
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 238000001816 cooling Methods 0.000 description 12
- 239000013543 active substance Substances 0.000 description 11
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 11
- 239000003054 catalyst Substances 0.000 description 11
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 11
- 239000002244 precipitate Substances 0.000 description 11
- 125000001424 substituent group Chemical group 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 10
- 239000003112 inhibitor Substances 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 9
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- 239000012280 lithium aluminium hydride Substances 0.000 description 9
- OPECTNGATDYLSS-UHFFFAOYSA-N naphthalene-2-sulfonyl chloride Chemical compound C1=CC=CC2=CC(S(=O)(=O)Cl)=CC=C21 OPECTNGATDYLSS-UHFFFAOYSA-N 0.000 description 9
- 229910000027 potassium carbonate Inorganic materials 0.000 description 9
- 235000011181 potassium carbonates Nutrition 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 229940122388 Thrombin inhibitor Drugs 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 8
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000012362 glacial acetic acid Substances 0.000 description 8
- 235000010288 sodium nitrite Nutrition 0.000 description 8
- 239000003868 thrombin inhibitor Substances 0.000 description 8
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 7
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 7
- 210000002381 plasma Anatomy 0.000 description 7
- 229940012957 plasmin Drugs 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 6
- 229910052794 bromium Inorganic materials 0.000 description 6
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 6
- 229910052740 iodine Inorganic materials 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- OIPPWFOQEKKFEE-UHFFFAOYSA-N orcinol Chemical compound CC1=CC(O)=CC(O)=C1 OIPPWFOQEKKFEE-UHFFFAOYSA-N 0.000 description 6
- 235000011118 potassium hydroxide Nutrition 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 239000012312 sodium hydride Substances 0.000 description 6
- 229910000104 sodium hydride Inorganic materials 0.000 description 6
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 5
- 108010049003 Fibrinogen Proteins 0.000 description 5
- 102000008946 Fibrinogen Human genes 0.000 description 5
- 229910010084 LiAlH4 Inorganic materials 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229940012952 fibrinogen Drugs 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 239000007868 Raney catalyst Substances 0.000 description 4
- 229910000564 Raney nickel Inorganic materials 0.000 description 4
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 230000029936 alkylation Effects 0.000 description 4
- 238000005804 alkylation reaction Methods 0.000 description 4
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 210000001772 blood platelet Anatomy 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 4
- 230000015271 coagulation Effects 0.000 description 4
- 238000005345 coagulation Methods 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 239000012458 free base Substances 0.000 description 4
- 239000012442 inert solvent Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- OKRHBEPHBRPPBV-UHFFFAOYSA-N n-[3-[2-[benzyl-(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]-5-methylphenyl]-2-methoxybenzenesulfonamide Chemical compound COC1=CC=CC=C1S(=O)(=O)NC1=CC(C)=CC(OCCN(CC=2C=CC=CC=2)C=2C(=C(Cl)N=C(Cl)C=2Cl)Cl)=C1 OKRHBEPHBRPPBV-UHFFFAOYSA-N 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- UACZEBCMUQWIIC-UHFFFAOYSA-N 2,3,5,6-tetrachloro-4-nitropyridine Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=NC(Cl)=C1Cl UACZEBCMUQWIIC-UHFFFAOYSA-N 0.000 description 3
- FMCOBIWFRSSGJF-UHFFFAOYSA-N 2-(3-hydroxy-5-methylphenyl)isoindole-1,3-dione Chemical compound CC1=CC(O)=CC(N2C(C3=CC=CC=C3C2=O)=O)=C1 FMCOBIWFRSSGJF-UHFFFAOYSA-N 0.000 description 3
- LIQUYSAGLDSLNI-UHFFFAOYSA-N 2-[benzyl-(2,3,5,6-tetrachloropyridin-4-yl)amino]ethyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCCN(C=1C(=C(Cl)N=C(Cl)C=1Cl)Cl)CC1=CC=CC=C1 LIQUYSAGLDSLNI-UHFFFAOYSA-N 0.000 description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 3
- VAVKLDLQKDLFNM-UHFFFAOYSA-N 3-amino-n-benzyl-5-chloro-n-phenylbenzenesulfonamide Chemical compound NC1=CC(Cl)=CC(S(=O)(=O)N(CC=2C=CC=CC=2)C=2C=CC=CC=2)=C1 VAVKLDLQKDLFNM-UHFFFAOYSA-N 0.000 description 3
- BFXHJFKKRGVUMU-UHFFFAOYSA-N 4-fluorobenzenesulfonyl chloride Chemical compound FC1=CC=C(S(Cl)(=O)=O)C=C1 BFXHJFKKRGVUMU-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 108010022999 Serine Proteases Proteins 0.000 description 3
- 102000012479 Serine Proteases Human genes 0.000 description 3
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical group O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 3
- 229910052796 boron Inorganic materials 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 3
- JSRQQAJJMRNTPQ-UHFFFAOYSA-N n-(3-amino-5-nitrophenyl)-n-methylbenzenesulfonamide Chemical compound C=1C=CC=CC=1S(=O)(=O)N(C)C1=CC(N)=CC([N+]([O-])=O)=C1 JSRQQAJJMRNTPQ-UHFFFAOYSA-N 0.000 description 3
- SDQOGULADYPQTK-UHFFFAOYSA-N n-[3-[2-[benzyl-(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]-5-methylphenyl]-2-phenylmethoxybenzenesulfonamide Chemical compound C=1C(OCCN(CC=2C=CC=CC=2)C=2C(=C(Cl)N=C(Cl)C=2Cl)Cl)=CC(C)=CC=1NS(=O)(=O)C1=CC=CC=C1OCC1=CC=CC=C1 SDQOGULADYPQTK-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- FYGHSUNMUKGBRK-UHFFFAOYSA-N 1,2,3-trimethylbenzene Chemical compound CC1=CC=CC(C)=C1C FYGHSUNMUKGBRK-UHFFFAOYSA-N 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- DNDPLEAVNVOOQZ-UHFFFAOYSA-N 2,3,4,5,6-pentachloropyridine Chemical compound ClC1=NC(Cl)=C(Cl)C(Cl)=C1Cl DNDPLEAVNVOOQZ-UHFFFAOYSA-N 0.000 description 2
- KXKCTSZYNCDFFG-UHFFFAOYSA-N 2-Methoxy-5-nitrophenol Chemical compound COC1=CC=C([N+]([O-])=O)C=C1O KXKCTSZYNCDFFG-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- CRSNXDFMUFKDSY-UHFFFAOYSA-N 2-[3-(2-chlorophenyl)sulfonyloxy-5-methylphenoxy]acetic acid Chemical compound CC1=CC(OCC(O)=O)=CC(OS(=O)(=O)C=2C(=CC=CC=2)Cl)=C1 CRSNXDFMUFKDSY-UHFFFAOYSA-N 0.000 description 2
- QGMYHDDYTWZBFU-UHFFFAOYSA-N 2-[3-[(4-fluorophenyl)sulfonylamino]-5-methylphenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C(OCC(=O)NC=2C=CN=CC=2)=CC(C)=CC=1NS(=O)(=O)C1=CC=C(F)C=C1 QGMYHDDYTWZBFU-UHFFFAOYSA-N 0.000 description 2
- GNVUIYMFALYXHN-UHFFFAOYSA-N 2-[3-methoxy-5-[methyl(phenyl)sulfamoyl]phenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C(S(=O)(=O)N(C)C=2C=CC=CC=2)=CC(OC)=CC=1OCC(=O)NC1=CC=NC=C1 GNVUIYMFALYXHN-UHFFFAOYSA-N 0.000 description 2
- UAQCFVCQLQMFJK-UHFFFAOYSA-N 2-[3-methoxy-5-[methyl(phenyl)sulfamoyl]phenoxy]acetic acid Chemical compound COC1=CC(OCC(O)=O)=CC(S(=O)(=O)N(C)C=2C=CC=CC=2)=C1 UAQCFVCQLQMFJK-UHFFFAOYSA-N 0.000 description 2
- ROLDZFVPKHWWJZ-UHFFFAOYSA-N 2-hydroxy-n-methyl-n-[3-methyl-5-[2-[(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]phenyl]benzenesulfonamide Chemical compound C=1C=CC=C(O)C=1S(=O)(=O)N(C)C(C=1)=CC(C)=CC=1OCCNC1=C(Cl)C(Cl)=NC(Cl)=C1Cl ROLDZFVPKHWWJZ-UHFFFAOYSA-N 0.000 description 2
- UMFDLIXUUJMPSI-UHFFFAOYSA-N 2-methyl-5-nitrophenol Chemical compound CC1=CC=C([N+]([O-])=O)C=C1O UMFDLIXUUJMPSI-UHFFFAOYSA-N 0.000 description 2
- YTLRWVNYANKXOW-UHFFFAOYSA-N 3,5-dimethoxybenzamide Chemical compound COC1=CC(OC)=CC(C(N)=O)=C1 YTLRWVNYANKXOW-UHFFFAOYSA-N 0.000 description 2
- IWPZKOJSYQZABD-UHFFFAOYSA-N 3,5-dimethoxybenzoic acid Chemical compound COC1=CC(OC)=CC(C(O)=O)=C1 IWPZKOJSYQZABD-UHFFFAOYSA-N 0.000 description 2
- MPBZUKLDHPOCLS-UHFFFAOYSA-N 3,5-dinitroaniline Chemical compound NC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1 MPBZUKLDHPOCLS-UHFFFAOYSA-N 0.000 description 2
- NCUABBHFJSFKOJ-UHFFFAOYSA-N 3-amino-5-methylphenol Chemical compound CC1=CC(N)=CC(O)=C1 NCUABBHFJSFKOJ-UHFFFAOYSA-N 0.000 description 2
- XWTWZZFSPBHOIF-UHFFFAOYSA-N 3-amino-n-methyl-n-phenylbenzenesulfonamide Chemical compound C=1C=CC(N)=CC=1S(=O)(=O)N(C)C1=CC=CC=C1 XWTWZZFSPBHOIF-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- SXSDROZIHKPCDJ-UHFFFAOYSA-N 3-hydroxy-N-methyl-N-phenylbenzenesulfonamide Chemical compound C=1C=CC(O)=CC=1S(=O)(=O)N(C)C1=CC=CC=C1 SXSDROZIHKPCDJ-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- MOOOPNRPJGZXPE-UHFFFAOYSA-N 4-methyl-2,6-dinitroaniline Chemical compound CC1=CC([N+]([O-])=O)=C(N)C([N+]([O-])=O)=C1 MOOOPNRPJGZXPE-UHFFFAOYSA-N 0.000 description 2
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- PZASAAIJIFDWSB-CKPDSHCKSA-N 8-[(1S)-1-[8-(trifluoromethyl)-7-[4-(trifluoromethyl)cyclohexyl]oxynaphthalen-2-yl]ethyl]-8-azabicyclo[3.2.1]octane-3-carboxylic acid Chemical compound FC(F)(F)C=1C2=CC([C@@H](N3C4CCC3CC(C4)C(O)=O)C)=CC=C2C=CC=1OC1CCC(C(F)(F)F)CC1 PZASAAIJIFDWSB-CKPDSHCKSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 101100516568 Caenorhabditis elegans nhr-7 gene Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 108010074860 Factor Xa Proteins 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 239000012448 Lithium borohydride Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 229910000091 aluminium hydride Inorganic materials 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 2
- 239000000292 calcium oxide Substances 0.000 description 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 2
- 150000007942 carboxylates Chemical group 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- IYYZUPMFVPLQIF-UHFFFAOYSA-N dibenzothiophene Chemical compound C1=CC=C2C3=CC=CC=C3SC2=C1 IYYZUPMFVPLQIF-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- NNTWKTYJRDRORV-UHFFFAOYSA-N ethyl 2-(3-amino-5-methylphenoxy)acetate Chemical compound CCOC(=O)COC1=CC(C)=CC(N)=C1 NNTWKTYJRDRORV-UHFFFAOYSA-N 0.000 description 2
- IVWPPUWTINZQIK-UHFFFAOYSA-N ethyl 2-(3-aminophenoxy)acetate Chemical compound CCOC(=O)COC1=CC=CC(N)=C1 IVWPPUWTINZQIK-UHFFFAOYSA-N 0.000 description 2
- DMPGIISXZJZHRI-UHFFFAOYSA-N ethyl 2-(3-aminophenoxy)propanoate Chemical compound CCOC(=O)C(C)OC1=CC=CC(N)=C1 DMPGIISXZJZHRI-UHFFFAOYSA-N 0.000 description 2
- DRKNYASFYDSFAJ-UHFFFAOYSA-N ethyl 2-[3-(benzenesulfonamido)phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(NS(=O)(=O)C=2C=CC=CC=2)=C1 DRKNYASFYDSFAJ-UHFFFAOYSA-N 0.000 description 2
- VEUUMBGHMNQHGO-UHFFFAOYSA-N ethyl chloroacetate Chemical compound CCOC(=O)CCl VEUUMBGHMNQHGO-UHFFFAOYSA-N 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- HJIQKNUTHDKLDJ-UHFFFAOYSA-N n-[2-(3-amino-5-methylphenoxy)ethyl]-n-benzyl-2,3,5,6-tetrachloropyridin-4-amine Chemical compound CC1=CC(N)=CC(OCCN(CC=2C=CC=CC=2)C=2C(=C(Cl)N=C(Cl)C=2Cl)Cl)=C1 HJIQKNUTHDKLDJ-UHFFFAOYSA-N 0.000 description 2
- HCNPDQDLVAAXAO-UHFFFAOYSA-N n-[3-[2-[benzyl-(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]-5-methylphenyl]-n-methyl-2-phenylmethoxybenzenesulfonamide Chemical compound C=1C=CC=C(OCC=2C=CC=CC=2)C=1S(=O)(=O)N(C)C(C=1)=CC(C)=CC=1OCCN(C=1C(=C(Cl)N=C(Cl)C=1Cl)Cl)CC1=CC=CC=C1 HCNPDQDLVAAXAO-UHFFFAOYSA-N 0.000 description 2
- UYGQGVPYEQIZQG-UHFFFAOYSA-N n-benzyl-3,5-dinitro-n-phenylbenzenesulfonamide Chemical compound [O-][N+](=O)C1=CC([N+]([O-])=O)=CC(S(=O)(=O)N(CC=2C=CC=CC=2)C=2C=CC=CC=2)=C1 UYGQGVPYEQIZQG-UHFFFAOYSA-N 0.000 description 2
- GTWJETSWSUWSEJ-UHFFFAOYSA-N n-benzylaniline Chemical compound C=1C=CC=CC=1CNC1=CC=CC=C1 GTWJETSWSUWSEJ-UHFFFAOYSA-N 0.000 description 2
- DBMIIFUNCPIMKI-UHFFFAOYSA-N n-methyl-3-nitro-n-phenylbenzenesulfonamide Chemical compound C=1C=CC([N+]([O-])=O)=CC=1S(=O)(=O)N(C)C1=CC=CC=C1 DBMIIFUNCPIMKI-UHFFFAOYSA-N 0.000 description 2
- ISRXMEYARGEVIU-UHFFFAOYSA-N n-methyl-n-propan-2-ylpropan-2-amine Chemical compound CC(C)N(C)C(C)C ISRXMEYARGEVIU-UHFFFAOYSA-N 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- DASJFYAPNPUBGG-UHFFFAOYSA-N naphthalene-1-sulfonyl chloride Chemical compound C1=CC=C2C(S(=O)(=O)Cl)=CC=CC2=C1 DASJFYAPNPUBGG-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- LGRFSURHDFAFJT-UHFFFAOYSA-N phthalic anhydride Chemical compound C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920000137 polyphosphoric acid Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000012429 reaction media Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003459 sulfonic acid esters Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VNNLHYZDXIBHKZ-UHFFFAOYSA-N thiophene-2-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CS1 VNNLHYZDXIBHKZ-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 239000002753 trypsin inhibitor Substances 0.000 description 2
- 239000011345 viscous material Substances 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- SRKDUHUULIWXFT-UHFFFAOYSA-N (2,2-dimethyl-1,3-dioxolan-4-yl)methyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCC1OC(C)(C)OC1 SRKDUHUULIWXFT-UHFFFAOYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- ZKKHRDAIBSQOQR-UHFFFAOYSA-N (3-amino-5-methylphenyl) benzenesulfonate Chemical compound CC1=CC(N)=CC(OS(=O)(=O)C=2C=CC=CC=2)=C1 ZKKHRDAIBSQOQR-UHFFFAOYSA-N 0.000 description 1
- JSNMCXOHGIDOBD-UHFFFAOYSA-N (3-chloro-5-hydroxyphenyl) 2-chlorobenzenesulfonate Chemical compound OC1=CC(Cl)=CC(OS(=O)(=O)C=2C(=CC=CC=2)Cl)=C1 JSNMCXOHGIDOBD-UHFFFAOYSA-N 0.000 description 1
- FERMVAKZCAIBIM-UHFFFAOYSA-N (3-chloro-5-hydroxyphenyl) benzenesulfonate Chemical compound OC1=CC(Cl)=CC(OS(=O)(=O)C=2C=CC=CC=2)=C1 FERMVAKZCAIBIM-UHFFFAOYSA-N 0.000 description 1
- OMOUASUPJKTTPN-UHFFFAOYSA-N (3-ethyl-5-hydroxyphenyl) benzenesulfonate Chemical compound CCC1=CC(O)=CC(OS(=O)(=O)C=2C=CC=CC=2)=C1 OMOUASUPJKTTPN-UHFFFAOYSA-N 0.000 description 1
- NOORCWSVEGUACV-UHFFFAOYSA-N (3-hydroxy-5-methylphenyl) thiophene-2-sulfonate Chemical compound OC=1C=C(C=C(C1)C)OS(=O)(=O)C=1SC=CC1 NOORCWSVEGUACV-UHFFFAOYSA-N 0.000 description 1
- ABHCMLPBMKURJO-UHFFFAOYSA-N (3-hydroxyphenyl) benzenesulfonate Chemical compound OC1=CC=CC(OS(=O)(=O)C=2C=CC=CC=2)=C1 ABHCMLPBMKURJO-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- YJKHOUIVWKQRSL-UHFFFAOYSA-N 1-(3,5-dimethoxyphenyl)ethanone Chemical compound COC1=CC(OC)=CC(C(C)=O)=C1 YJKHOUIVWKQRSL-UHFFFAOYSA-N 0.000 description 1
- UJPKMTDFFUTLGM-UHFFFAOYSA-N 1-aminoethanol Chemical class CC(N)O UJPKMTDFFUTLGM-UHFFFAOYSA-N 0.000 description 1
- WYYRQMZTUXFUTC-UHFFFAOYSA-N 1-benzothiophene-3-sulfonyl chloride Chemical compound C1=CC=C2C(S(=O)(=O)Cl)=CSC2=C1 WYYRQMZTUXFUTC-UHFFFAOYSA-N 0.000 description 1
- OLDMYNWXIGPOCI-UHFFFAOYSA-N 1-bromo-3,5-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC(Br)=CC([N+]([O-])=O)=C1 OLDMYNWXIGPOCI-UHFFFAOYSA-N 0.000 description 1
- WQHNWJBSROXROL-UHFFFAOYSA-N 1-chloro-3,5-dimethoxybenzene Chemical compound COC1=CC(Cl)=CC(OC)=C1 WQHNWJBSROXROL-UHFFFAOYSA-N 0.000 description 1
- CDQDCHVJLUPXEF-UHFFFAOYSA-N 1-ethyl-3,5-dimethoxybenzene Chemical compound CCC1=CC(OC)=CC(OC)=C1 CDQDCHVJLUPXEF-UHFFFAOYSA-N 0.000 description 1
- CGXLLADFCNZBIN-UHFFFAOYSA-N 1-methyl-2h-pyridin-2-amine Chemical compound CN1C=CC=CC1N CGXLLADFCNZBIN-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- PDQRQJVPEFGVRK-UHFFFAOYSA-N 2,1,3-benzothiadiazole Chemical compound C1=CC=CC2=NSN=C21 PDQRQJVPEFGVRK-UHFFFAOYSA-N 0.000 description 1
- CXAICGCTHOWKPP-UHFFFAOYSA-N 2,1,3-benzothiadiazole-4-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC2=NSN=C12 CXAICGCTHOWKPP-UHFFFAOYSA-N 0.000 description 1
- AWBOSXFRPFZLOP-UHFFFAOYSA-N 2,1,3-benzoxadiazole Chemical compound C1=CC=CC2=NON=C21 AWBOSXFRPFZLOP-UHFFFAOYSA-N 0.000 description 1
- DDQPOYVWHPDXOX-UHFFFAOYSA-N 2,3-dinitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=CC(S(Cl)(=O)=O)=C1[N+]([O-])=O DDQPOYVWHPDXOX-UHFFFAOYSA-N 0.000 description 1
- OMQKERNQORAPNJ-UHFFFAOYSA-N 2-(1,3-dioxoisoindol-2-yl)ethyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCCN1C(=O)C2=CC=CC=C2C1=O OMQKERNQORAPNJ-UHFFFAOYSA-N 0.000 description 1
- MWFLUYFYHANMCM-UHFFFAOYSA-N 2-(2-hydroxyethyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCO)C(=O)C2=C1 MWFLUYFYHANMCM-UHFFFAOYSA-N 0.000 description 1
- YMHGHPBDBIKSPR-UHFFFAOYSA-N 2-(3-amino-5-bromoanilino)-n-pyridin-4-ylacetamide Chemical compound NC1=CC(Br)=CC(NCC(=O)NC=2C=CN=CC=2)=C1 YMHGHPBDBIKSPR-UHFFFAOYSA-N 0.000 description 1
- BOFPJVUEKCNBCI-UHFFFAOYSA-N 2-(3-aminoanilino)-n-pyridin-4-ylacetamide Chemical compound NC1=CC=CC(NCC(=O)NC=2C=CN=CC=2)=C1 BOFPJVUEKCNBCI-UHFFFAOYSA-N 0.000 description 1
- BCIKGGLREGZMIG-UHFFFAOYSA-N 2-(3-bromo-5-nitroanilino)-n-pyridin-4-ylacetamide Chemical compound [O-][N+](=O)C1=CC(Br)=CC(NCC(=O)NC=2C=CN=CC=2)=C1 BCIKGGLREGZMIG-UHFFFAOYSA-N 0.000 description 1
- LRVDQIAQSWUPHL-UHFFFAOYSA-N 2-(3-nitroanilino)-n-pyridin-4-ylacetamide Chemical compound [O-][N+](=O)C1=CC=CC(NCC(=O)NC=2C=CN=CC=2)=C1 LRVDQIAQSWUPHL-UHFFFAOYSA-N 0.000 description 1
- YWWRLAPJIGCYRN-UHFFFAOYSA-N 2-(3-nitroanilino)acetic acid Chemical compound OC(=O)CNC1=CC=CC([N+]([O-])=O)=C1 YWWRLAPJIGCYRN-UHFFFAOYSA-N 0.000 description 1
- OOUZHYGJSBMPRF-UHFFFAOYSA-N 2-[(2,3,5,6-tetrachloropyridin-4-yl)amino]ethanol Chemical compound OCCNC1=C(Cl)C(Cl)=NC(Cl)=C1Cl OOUZHYGJSBMPRF-UHFFFAOYSA-N 0.000 description 1
- DFBKYMNYOHWGOW-UHFFFAOYSA-N 2-[(2,3,5,6-tetrachloropyridin-4-yl)amino]ethyl acetate Chemical compound CC(=O)OCCNC1=C(Cl)C(Cl)=NC(Cl)=C1Cl DFBKYMNYOHWGOW-UHFFFAOYSA-N 0.000 description 1
- YGENEYGLULNAGB-UHFFFAOYSA-N 2-[2-(pyridin-4-ylamino)ethoxy]benzenesulfonamide Chemical compound N1=CC=C(C=C1)NCCOC1=C(C=CC=C1)S(=O)(=O)N YGENEYGLULNAGB-UHFFFAOYSA-N 0.000 description 1
- RAQXUYLTVFJGRC-UHFFFAOYSA-N 2-[3-(benzenesulfonamido)-5-methylphenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C(OCC(=O)NC=2C=CN=CC=2)=CC(C)=CC=1NS(=O)(=O)C1=CC=CC=C1 RAQXUYLTVFJGRC-UHFFFAOYSA-N 0.000 description 1
- WPDNOZDWBIIXOD-UHFFFAOYSA-N 2-[3-(benzenesulfonamido)-5-methylphenoxy]acetic acid Chemical compound OC(=O)COC1=CC(C)=CC(NS(=O)(=O)C=2C=CC=CC=2)=C1 WPDNOZDWBIIXOD-UHFFFAOYSA-N 0.000 description 1
- LDTCKWKGPGYVRY-UHFFFAOYSA-N 2-[3-(benzenesulfonamido)anilino]-n-pyridin-4-ylacetamide Chemical compound C=1C=NC=CC=1NC(=O)CNC(C=1)=CC=CC=1NS(=O)(=O)C1=CC=CC=C1 LDTCKWKGPGYVRY-UHFFFAOYSA-N 0.000 description 1
- GMWNQMQTNVHXGW-UHFFFAOYSA-N 2-[3-(benzenesulfonamido)phenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C=NC=CC=1NC(=O)COC(C=1)=CC=CC=1NS(=O)(=O)C1=CC=CC=C1 GMWNQMQTNVHXGW-UHFFFAOYSA-N 0.000 description 1
- YWNYIBWFXWPNCS-UHFFFAOYSA-N 2-[3-(benzenesulfonamido)phenoxy]-n-pyridin-4-ylpropanamide Chemical compound C=1C=NC=CC=1NC(=O)C(C)OC(C=1)=CC=CC=1NS(=O)(=O)C1=CC=CC=C1 YWNYIBWFXWPNCS-UHFFFAOYSA-N 0.000 description 1
- CRHFFPBNCFZWAJ-UHFFFAOYSA-N 2-[3-(benzenesulfonamido)phenoxy]propanoic acid Chemical compound OC(=O)C(C)OC1=CC=CC(NS(=O)(=O)C=2C=CC=CC=2)=C1 CRHFFPBNCFZWAJ-UHFFFAOYSA-N 0.000 description 1
- YBSVKJHKYKTGJG-UHFFFAOYSA-N 2-[3-(benzenesulfonyloxy)-5-chlorophenoxy]acetic acid Chemical compound OC(=O)COC1=CC(Cl)=CC(OS(=O)(=O)C=2C=CC=CC=2)=C1 YBSVKJHKYKTGJG-UHFFFAOYSA-N 0.000 description 1
- BRAGIJSFEUUAAP-UHFFFAOYSA-N 2-[3-(benzenesulfonyloxy)-5-ethylphenoxy]acetic acid Chemical compound CCC1=CC(OCC(O)=O)=CC(OS(=O)(=O)C=2C=CC=CC=2)=C1 BRAGIJSFEUUAAP-UHFFFAOYSA-N 0.000 description 1
- RXJMBAYFOAOOQM-UHFFFAOYSA-N 2-[3-(benzenesulfonyloxy)-5-methylphenoxy]acetic acid Chemical compound CC1=CC(OCC(O)=O)=CC(OS(=O)(=O)C=2C=CC=CC=2)=C1 RXJMBAYFOAOOQM-UHFFFAOYSA-N 0.000 description 1
- WTPIWRSVEWBELH-UHFFFAOYSA-N 2-[3-(benzenesulfonyloxy)anilino]acetic acid Chemical compound OC(=O)CNC1=CC=CC(OS(=O)(=O)C=2C=CC=CC=2)=C1 WTPIWRSVEWBELH-UHFFFAOYSA-N 0.000 description 1
- UJQKXZDRSQECNS-UHFFFAOYSA-N 2-[3-(benzenesulfonyloxy)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=CC(OS(=O)(=O)C=2C=CC=CC=2)=C1 UJQKXZDRSQECNS-UHFFFAOYSA-N 0.000 description 1
- CHXQVFCHBAEJPY-UHFFFAOYSA-N 2-[3-(cyclohexylsulfonylamino)phenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C=NC=CC=1NC(=O)COC(C=1)=CC=CC=1NS(=O)(=O)C1CCCCC1 CHXQVFCHBAEJPY-UHFFFAOYSA-N 0.000 description 1
- WDDPXVDMJFQZQD-UHFFFAOYSA-N 2-[3-(cyclohexylsulfonylamino)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=CC(NS(=O)(=O)C2CCCCC2)=C1 WDDPXVDMJFQZQD-UHFFFAOYSA-N 0.000 description 1
- UNAPDULPRVQOHL-UHFFFAOYSA-N 2-[3-(naphthalen-1-ylsulfonylamino)phenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C=CC(NS(=O)(=O)C=2C3=CC=CC=C3C=CC=2)=CC=1OCC(=O)NC1=CC=NC=C1 UNAPDULPRVQOHL-UHFFFAOYSA-N 0.000 description 1
- RDTXUQPIZWSGOB-UHFFFAOYSA-N 2-[3-(naphthalen-1-ylsulfonylamino)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=CC(NS(=O)(=O)C=2C3=CC=CC=C3C=CC=2)=C1 RDTXUQPIZWSGOB-UHFFFAOYSA-N 0.000 description 1
- UMOXSIWSYLWHAC-UHFFFAOYSA-N 2-[3-(naphthalen-2-ylsulfonylamino)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=CC(NS(=O)(=O)C=2C=C3C=CC=CC3=CC=2)=C1 UMOXSIWSYLWHAC-UHFFFAOYSA-N 0.000 description 1
- QBVNABYLXFPMMI-UHFFFAOYSA-N 2-[3-[(2-chloro-4-fluorophenyl)sulfonylamino]-5-methylphenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C(OCC(=O)NC=2C=CN=CC=2)=CC(C)=CC=1NS(=O)(=O)C1=CC=C(F)C=C1Cl QBVNABYLXFPMMI-UHFFFAOYSA-N 0.000 description 1
- VRZWGMLOQGFAIQ-UHFFFAOYSA-N 2-[3-[(2-chlorophenyl)sulfonyl-methylamino]-5-methylphenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C=CC=C(Cl)C=1S(=O)(=O)N(C)C(C=1)=CC(C)=CC=1OCC(=O)NC1=CC=NC=C1 VRZWGMLOQGFAIQ-UHFFFAOYSA-N 0.000 description 1
- HIOKBRRLGWSFEL-UHFFFAOYSA-N 2-[3-[(2-chlorophenyl)sulfonyl-methylamino]-5-methylphenoxy]acetic acid Chemical compound CN(C=1C=C(OCC(=O)O)C=C(C1)C)S(=O)(=O)C1=C(C=CC=C1)Cl HIOKBRRLGWSFEL-UHFFFAOYSA-N 0.000 description 1
- WUBLRRJQEVIRKZ-UHFFFAOYSA-N 2-[3-[(3,5-dimethyl-1h-pyrazol-4-yl)sulfonylamino]-5-methylphenoxy]-n-pyridin-4-ylacetamide Chemical compound CC1=NNC(C)=C1S(=O)(=O)NC1=CC(C)=CC(OCC(=O)NC=2C=CN=CC=2)=C1 WUBLRRJQEVIRKZ-UHFFFAOYSA-N 0.000 description 1
- DLNGHZIGARKJNT-UHFFFAOYSA-N 2-[3-[(4-chlorophenyl)sulfonylamino]phenoxy]-n-pyridin-4-ylacetamide Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)NC1=CC=CC(OCC(=O)NC=2C=CN=CC=2)=C1 DLNGHZIGARKJNT-UHFFFAOYSA-N 0.000 description 1
- JNQJAEZYLVLZKP-UHFFFAOYSA-N 2-[3-[(4-chlorophenyl)sulfonylamino]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=CC(NS(=O)(=O)C=2C=CC(Cl)=CC=2)=C1 JNQJAEZYLVLZKP-UHFFFAOYSA-N 0.000 description 1
- XORZSPOZIPIIPP-UHFFFAOYSA-N 2-[3-[(4-fluorophenyl)sulfonylamino]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=CC(NS(=O)(=O)C=2C=CC(F)=CC=2)=C1 XORZSPOZIPIIPP-UHFFFAOYSA-N 0.000 description 1
- XOIYGWBXMXCTBE-UHFFFAOYSA-N 2-[3-[(4-methylphenyl)sulfonylamino]phenoxy]-n-pyridin-4-ylacetamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=CC=CC(OCC(=O)NC=2C=CN=CC=2)=C1 XOIYGWBXMXCTBE-UHFFFAOYSA-N 0.000 description 1
- DJGDJQIYMUEREI-UHFFFAOYSA-N 2-[3-[(4-methylphenyl)sulfonylamino]phenoxy]acetic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=CC=CC(OCC(O)=O)=C1 DJGDJQIYMUEREI-UHFFFAOYSA-N 0.000 description 1
- GQCHJGMUXPVOPX-UHFFFAOYSA-N 2-[3-[(5-fluoro-2-methylphenyl)sulfonyl-methylamino]-5-methylphenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C(F)=CC=C(C)C=1S(=O)(=O)N(C)C(C=1)=CC(C)=CC=1OCC(=O)NC1=CC=NC=C1 GQCHJGMUXPVOPX-UHFFFAOYSA-N 0.000 description 1
- ITSWLTZBHJCGCU-UHFFFAOYSA-N 2-[3-[(5-fluoro-2-methylphenyl)sulfonylamino]-5-methylphenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C(OCC(=O)NC=2C=CN=CC=2)=CC(C)=CC=1NS(=O)(=O)C1=CC(F)=CC=C1C ITSWLTZBHJCGCU-UHFFFAOYSA-N 0.000 description 1
- XUJUTMCNLAXRTM-UHFFFAOYSA-N 2-[3-[2-[benzyl-(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]-5-methylphenyl]isoindole-1,3-dione Chemical compound C=1C(N2C(C3=CC=CC=C3C2=O)=O)=CC(C)=CC=1OCCN(C=1C(=C(Cl)N=C(Cl)C=1Cl)Cl)CC1=CC=CC=C1 XUJUTMCNLAXRTM-UHFFFAOYSA-N 0.000 description 1
- FSOUPLRQZDFQCT-UHFFFAOYSA-N 2-[3-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=CC(NS(=O)(=O)C=2C=C(C=CC=2)C(F)(F)F)=C1 FSOUPLRQZDFQCT-UHFFFAOYSA-N 0.000 description 1
- URIHMGJARASFBZ-UHFFFAOYSA-N 2-[3-[[3-methyl-5-[2-(pyridin-4-ylamino)ethoxy]phenyl]sulfamoyl]phenoxy]acetamide Chemical compound C=1C(OCCNC=2C=CN=CC=2)=CC(C)=CC=1NS(=O)(=O)C1=CC=CC(OCC(N)=O)=C1 URIHMGJARASFBZ-UHFFFAOYSA-N 0.000 description 1
- BMHSGEHXQBTXKJ-UHFFFAOYSA-N 2-[3-[[3-methyl-5-[2-(pyridin-4-ylamino)ethoxy]phenyl]sulfamoyl]phenoxy]acetic acid Chemical compound C=1C(OCCNC=2C=CN=CC=2)=CC(C)=CC=1NS(=O)(=O)C1=CC=CC(OCC(O)=O)=C1 BMHSGEHXQBTXKJ-UHFFFAOYSA-N 0.000 description 1
- RHOVFMAYSIZNSG-UHFFFAOYSA-N 2-[3-[[4-(trifluoromethyl)phenyl]sulfonylamino]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=CC(NS(=O)(=O)C=2C=CC(=CC=2)C(F)(F)F)=C1 RHOVFMAYSIZNSG-UHFFFAOYSA-N 0.000 description 1
- ARRSFBSQQIAYSM-UHFFFAOYSA-N 2-[3-[benzenesulfonyl(benzyl)amino]-5-chlorophenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C(N(CC=2C=CC=CC=2)S(=O)(=O)C=2C=CC=CC=2)=CC(Cl)=CC=1OCC(=O)NC1=CC=NC=C1 ARRSFBSQQIAYSM-UHFFFAOYSA-N 0.000 description 1
- NQICJXWXOXDOKC-UHFFFAOYSA-N 2-[3-[benzenesulfonyl(benzyl)amino]-5-chlorophenoxy]acetic acid Chemical compound ClC=1C=C(OCC(=O)O)C=C(C1)N(CC1=CC=CC=C1)S(=O)(=O)C1=CC=CC=C1 NQICJXWXOXDOKC-UHFFFAOYSA-N 0.000 description 1
- HIYBDKWOMGMLMM-UHFFFAOYSA-N 2-[3-[benzenesulfonyl(benzyl)amino]phenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C=NC=CC=1NC(=O)COC(C=1)=CC=CC=1N(S(=O)(=O)C=1C=CC=CC=1)CC1=CC=CC=C1 HIYBDKWOMGMLMM-UHFFFAOYSA-N 0.000 description 1
- XPAPOBNPQNKNMR-UHFFFAOYSA-N 2-[3-[benzenesulfonyl(benzyl)amino]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=CC(N(CC=2C=CC=CC=2)S(=O)(=O)C=2C=CC=CC=2)=C1 XPAPOBNPQNKNMR-UHFFFAOYSA-N 0.000 description 1
- NWVYMUOMWLFQEJ-UHFFFAOYSA-N 2-[3-[benzenesulfonyl(ethyl)amino]phenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C=CC=CC=1S(=O)(=O)N(CC)C(C=1)=CC=CC=1OCC(=O)NC1=CC=NC=C1 NWVYMUOMWLFQEJ-UHFFFAOYSA-N 0.000 description 1
- OUBDVJLUVJUQOA-UHFFFAOYSA-N 2-[3-[benzenesulfonyl(ethyl)amino]phenoxy]acetic acid Chemical compound C=1C=CC=CC=1S(=O)(=O)N(CC)C1=CC=CC(OCC(O)=O)=C1 OUBDVJLUVJUQOA-UHFFFAOYSA-N 0.000 description 1
- CEAIUFLINYPBGJ-UHFFFAOYSA-N 2-[3-[benzenesulfonyl(methyl)amino]-5-chlorophenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C=CC=CC=1S(=O)(=O)N(C)C(C=1)=CC(Cl)=CC=1OCC(=O)NC1=CC=NC=C1 CEAIUFLINYPBGJ-UHFFFAOYSA-N 0.000 description 1
- ZTTFOPOTXBBJRO-UHFFFAOYSA-N 2-[3-[benzenesulfonyl(methyl)amino]-5-methoxyphenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C(N(C)S(=O)(=O)C=2C=CC=CC=2)=CC(OC)=CC=1OCC(=O)NC1=CC=NC=C1 ZTTFOPOTXBBJRO-UHFFFAOYSA-N 0.000 description 1
- RWIJJZNCMQLACJ-UHFFFAOYSA-N 2-[3-[benzenesulfonyl(methyl)amino]-5-methoxyphenoxy]acetic acid Chemical compound COC=1C=C(OCC(=O)O)C=C(C=1)N(C)S(=O)(=O)C1=CC=CC=C1 RWIJJZNCMQLACJ-UHFFFAOYSA-N 0.000 description 1
- DRIVLQBICQGKFP-UHFFFAOYSA-N 2-[3-[benzenesulfonyl(methyl)amino]phenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C=CC=CC=1S(=O)(=O)N(C)C(C=1)=CC=CC=1OCC(=O)NC1=CC=NC=C1 DRIVLQBICQGKFP-UHFFFAOYSA-N 0.000 description 1
- MLHAPMMSQYHLLY-UHFFFAOYSA-N 2-[3-[benzenesulfonyl(methyl)amino]phenoxy]acetic acid Chemical compound C=1C=CC=CC=1S(=O)(=O)N(C)C1=CC=CC(OCC(O)=O)=C1 MLHAPMMSQYHLLY-UHFFFAOYSA-N 0.000 description 1
- SKMPBIMQGXDGLV-UHFFFAOYSA-N 2-[3-[benzenesulfonyl(propyl)amino]phenoxy]-N-pyridin-4-ylacetamide Chemical compound CCCN(c1cccc(OCC(=O)Nc2ccncc2)c1)S(=O)(=O)c1ccccc1 SKMPBIMQGXDGLV-UHFFFAOYSA-N 0.000 description 1
- NOTSKYHNXHKGIS-UHFFFAOYSA-N 2-[3-[benzenesulfonyl(propyl)amino]phenoxy]acetic acid Chemical compound C=1C=CC=CC=1S(=O)(=O)N(CCC)C1=CC=CC(OCC(O)=O)=C1 NOTSKYHNXHKGIS-UHFFFAOYSA-N 0.000 description 1
- QENVLEGQWRMQRQ-UHFFFAOYSA-N 2-[3-[benzyl(phenyl)sulfamoyl]-5-chloroanilino]-n-pyridin-4-ylacetamide Chemical compound C=1C(S(=O)(=O)N(CC=2C=CC=CC=2)C=2C=CC=CC=2)=CC(Cl)=CC=1NCC(=O)NC1=CC=NC=C1 QENVLEGQWRMQRQ-UHFFFAOYSA-N 0.000 description 1
- AJTANPGGJQRXAX-UHFFFAOYSA-N 2-[3-[benzyl(phenyl)sulfamoyl]-5-chloroanilino]acetic acid Chemical compound OC(=O)CNC1=CC(Cl)=CC(S(=O)(=O)N(CC=2C=CC=CC=2)C=2C=CC=CC=2)=C1 AJTANPGGJQRXAX-UHFFFAOYSA-N 0.000 description 1
- DVLOMSVSNPPQEJ-UHFFFAOYSA-N 2-[3-[benzyl(phenyl)sulfamoyl]-5-chlorophenoxy]acetic acid Chemical compound OC(=O)COC1=CC(Cl)=CC(S(=O)(=O)N(CC=2C=CC=CC=2)C=2C=CC=CC=2)=C1 DVLOMSVSNPPQEJ-UHFFFAOYSA-N 0.000 description 1
- HFLFXURLZIQGHS-UHFFFAOYSA-N 2-[3-[methyl(phenyl)sulfamoyl]phenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C=CC(OCC(=O)NC=2C=CN=CC=2)=CC=1S(=O)(=O)N(C)C1=CC=CC=C1 HFLFXURLZIQGHS-UHFFFAOYSA-N 0.000 description 1
- KUIMPJKVWBMXGD-UHFFFAOYSA-N 2-[3-[methyl(phenyl)sulfamoyl]phenoxy]acetic acid Chemical compound C=1C=CC(OCC(O)=O)=CC=1S(=O)(=O)N(C)C1=CC=CC=C1 KUIMPJKVWBMXGD-UHFFFAOYSA-N 0.000 description 1
- SCDQIFOUWQBECD-UHFFFAOYSA-N 2-[3-chloro-5-(2-chlorophenyl)sulfonyloxyphenoxy]acetic acid Chemical compound OC(=O)COC1=CC(Cl)=CC(OS(=O)(=O)C=2C(=CC=CC=2)Cl)=C1 SCDQIFOUWQBECD-UHFFFAOYSA-N 0.000 description 1
- VUBYMMTWQNMSBB-UHFFFAOYSA-N 2-[3-chloro-5-[methyl(phenyl)sulfamoyl]phenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C(Cl)=CC(OCC(=O)NC=2C=CN=CC=2)=CC=1S(=O)(=O)N(C)C1=CC=CC=C1 VUBYMMTWQNMSBB-UHFFFAOYSA-N 0.000 description 1
- SACGYAGCWSVEEZ-UHFFFAOYSA-N 2-[3-chloro-5-[methyl(phenyl)sulfamoyl]phenoxy]acetic acid Chemical compound C=1C(Cl)=CC(OCC(O)=O)=CC=1S(=O)(=O)N(C)C1=CC=CC=C1 SACGYAGCWSVEEZ-UHFFFAOYSA-N 0.000 description 1
- UCTAVSVFJLMNPX-UHFFFAOYSA-N 2-[3-methyl-5-(2-phenylmethoxycarbonylphenyl)sulfonyloxyphenoxy]acetic acid Chemical compound CC1=CC(OCC(O)=O)=CC(OS(=O)(=O)C=2C(=CC=CC=2)C(=O)OCC=2C=CC=CC=2)=C1 UCTAVSVFJLMNPX-UHFFFAOYSA-N 0.000 description 1
- CEECBASAIKGERG-UHFFFAOYSA-N 2-[3-methyl-5-[(2-methylphenyl)sulfonylamino]phenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C(OCC(=O)NC=2C=CN=CC=2)=CC(C)=CC=1NS(=O)(=O)C1=CC=CC=C1C CEECBASAIKGERG-UHFFFAOYSA-N 0.000 description 1
- LNHUXBVZNLOWPX-UHFFFAOYSA-N 2-[3-methyl-5-[methyl-(4-methylphenyl)sulfonylamino]phenoxy]-n-pyridin-4-ylacetamide Chemical compound C=1C=C(C)C=CC=1S(=O)(=O)N(C)C(C=1)=CC(C)=CC=1OCC(=O)NC1=CC=NC=C1 LNHUXBVZNLOWPX-UHFFFAOYSA-N 0.000 description 1
- LIMIBLLLXDZIHH-UHFFFAOYSA-N 2-[3-nitro-5-(trifluoromethyl)phenoxy]ethanamine Chemical compound NCCOC1=CC([N+]([O-])=O)=CC(C(F)(F)F)=C1 LIMIBLLLXDZIHH-UHFFFAOYSA-N 0.000 description 1
- HVTQDSGGHBWVTR-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-phenylmethoxypyrazol-1-yl]-1-morpholin-4-ylethanone Chemical compound C(C1=CC=CC=C1)OC1=NN(C=C1C=1C=NC(=NC=1)NC1CC2=CC=CC=C2C1)CC(=O)N1CCOCC1 HVTQDSGGHBWVTR-UHFFFAOYSA-N 0.000 description 1
- BIOAUKAGHVQFPB-UHFFFAOYSA-N 2-[5-(benzenesulfonamido)-2-methoxyphenoxy]-n-pyridin-4-ylacetamide Chemical compound C1=C(OCC(=O)NC=2C=CN=CC=2)C(OC)=CC=C1NS(=O)(=O)C1=CC=CC=C1 BIOAUKAGHVQFPB-UHFFFAOYSA-N 0.000 description 1
- VHXHLSIWRPIGNT-UHFFFAOYSA-N 2-[5-(benzenesulfonamido)-2-methoxyphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(OC)=CC=C1NS(=O)(=O)C1=CC=CC=C1 VHXHLSIWRPIGNT-UHFFFAOYSA-N 0.000 description 1
- KNGFGRPOXURKIA-UHFFFAOYSA-N 2-[5-(benzenesulfonamido)-2-methylphenoxy]-n-pyridin-4-ylacetamide Chemical compound C1=C(OCC(=O)NC=2C=CN=CC=2)C(C)=CC=C1NS(=O)(=O)C1=CC=CC=C1 KNGFGRPOXURKIA-UHFFFAOYSA-N 0.000 description 1
- PPNMOYHWPZWCDF-UHFFFAOYSA-N 2-[5-(benzenesulfonamido)-2-methylphenoxy]acetic acid Chemical compound C1=C(OCC(O)=O)C(C)=CC=C1NS(=O)(=O)C1=CC=CC=C1 PPNMOYHWPZWCDF-UHFFFAOYSA-N 0.000 description 1
- BVTAWEFZGUQIBI-UHFFFAOYSA-N 2-[benzyl-(2,3,5,6-tetrachloropyridin-4-yl)amino]ethanol Chemical compound ClC=1C(Cl)=NC(Cl)=C(Cl)C=1N(CCO)CC1=CC=CC=C1 BVTAWEFZGUQIBI-UHFFFAOYSA-N 0.000 description 1
- KDHGBXHAFAKFBP-UHFFFAOYSA-N 2-[benzyl-(2,3,5,6-tetrachloropyridin-4-yl)amino]ethyl acetate Chemical compound ClC=1C(Cl)=NC(Cl)=C(Cl)C=1N(CCOC(=O)C)CC1=CC=CC=C1 KDHGBXHAFAKFBP-UHFFFAOYSA-N 0.000 description 1
- CIHWVQDCKSGZQD-UHFFFAOYSA-N 2-amino-2-[3-(benzenesulfonyloxy)-5-methylphenyl]acetic acid Chemical compound C1(=CC=CC=C1)S(=O)(=O)OC=1C=C(C=C(C=1)C)C(C(=O)O)N CIHWVQDCKSGZQD-UHFFFAOYSA-N 0.000 description 1
- ZMCHBSMFKQYNKA-UHFFFAOYSA-N 2-aminobenzenesulfonic acid Chemical compound NC1=CC=CC=C1S(O)(=O)=O ZMCHBSMFKQYNKA-UHFFFAOYSA-N 0.000 description 1
- QWTADEJSRWWXBO-UHFFFAOYSA-N 2-bromo-2-(3-nitroanilino)acetic acid Chemical compound OC(=O)C(Br)NC1=CC=CC([N+]([O-])=O)=C1 QWTADEJSRWWXBO-UHFFFAOYSA-N 0.000 description 1
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 description 1
- KMVZDSQHLDGKGV-UHFFFAOYSA-N 2-chlorobenzenesulfonyl chloride Chemical compound ClC1=CC=CC=C1S(Cl)(=O)=O KMVZDSQHLDGKGV-UHFFFAOYSA-N 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- VOEUXQVGDRGYEP-UHFFFAOYSA-N 2-hydroxy-n-[3-methyl-5-[2-[(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]phenyl]benzenesulfonamide Chemical compound C=1C(OCCNC=2C(=C(Cl)N=C(Cl)C=2Cl)Cl)=CC(C)=CC=1NS(=O)(=O)C1=CC=CC=C1O VOEUXQVGDRGYEP-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- GYOBZOBUOMDRRN-UHFFFAOYSA-N 2-methoxybenzenesulfonyl chloride Chemical compound COC1=CC=CC=C1S(Cl)(=O)=O GYOBZOBUOMDRRN-UHFFFAOYSA-N 0.000 description 1
- XLBHXAPKYJTOJQ-UHFFFAOYSA-N 2-phenylmethoxybenzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1OCC1=CC=CC=C1 XLBHXAPKYJTOJQ-UHFFFAOYSA-N 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- RUIFULUFLANOCI-UHFFFAOYSA-N 3,5-Dinitrotoluene Chemical compound CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1 RUIFULUFLANOCI-UHFFFAOYSA-N 0.000 description 1
- ZEBAGWISRATDJH-UHFFFAOYSA-N 3,5-dinitrobenzoyl azide Chemical compound [O-][N+](=O)C1=CC(C(=O)N=[N+]=[N-])=CC([N+]([O-])=O)=C1 ZEBAGWISRATDJH-UHFFFAOYSA-N 0.000 description 1
- NNOHXABAQAGKRZ-UHFFFAOYSA-N 3,5-dinitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC(C(Cl)=O)=CC([N+]([O-])=O)=C1 NNOHXABAQAGKRZ-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- ONCAZCNPWWQQMW-UHFFFAOYSA-N 3-(trifluoromethyl)benzenesulfonyl chloride Chemical compound FC(F)(F)C1=CC=CC(S(Cl)(=O)=O)=C1 ONCAZCNPWWQQMW-UHFFFAOYSA-N 0.000 description 1
- OFLPGQASYARQJZ-UHFFFAOYSA-N 3-[3-(benzenesulfonamido)phenoxy]-N-pyridin-4-ylbutanamide Chemical compound C1(=CC=CC=C1)S(=O)(=O)NC1=CC(=CC=C1)OC(CC(=O)NC1=CC=NC=C1)C OFLPGQASYARQJZ-UHFFFAOYSA-N 0.000 description 1
- ZCPCDYSBDQXGAE-UHFFFAOYSA-N 3-[3-(benzenesulfonamido)phenoxy]butanoic acid Chemical compound OC(=O)CC(C)OC1=CC=CC(NS(=O)(=O)C=2C=CC=CC=2)=C1 ZCPCDYSBDQXGAE-UHFFFAOYSA-N 0.000 description 1
- QVPYTVVOHGKOBR-UHFFFAOYSA-N 3-amino-5-chloro-n-methyl-n-phenylbenzenesulfonamide Chemical compound C=1C(N)=CC(Cl)=CC=1S(=O)(=O)N(C)C1=CC=CC=C1 QVPYTVVOHGKOBR-UHFFFAOYSA-N 0.000 description 1
- ZXTKWVGUKROSJS-UHFFFAOYSA-N 3-amino-5-methoxy-n-methyl-n-phenylbenzenesulfonamide Chemical compound COC1=CC(N)=CC(S(=O)(=O)N(C)C=2C=CC=CC=2)=C1 ZXTKWVGUKROSJS-UHFFFAOYSA-N 0.000 description 1
- ILTCFIIXWWUIPC-UHFFFAOYSA-N 3-amino-5-methoxyphenol Chemical compound COC1=CC(N)=CC(O)=C1 ILTCFIIXWWUIPC-UHFFFAOYSA-N 0.000 description 1
- SPADOWBBSWXZNO-UHFFFAOYSA-N 3-amino-n-benzyl-5-methoxy-n-phenylbenzenesulfonamide Chemical compound COC1=CC(N)=CC(S(=O)(=O)N(CC=2C=CC=CC=2)C=2C=CC=CC=2)=C1 SPADOWBBSWXZNO-UHFFFAOYSA-N 0.000 description 1
- RCMDDBWIELLOAV-UHFFFAOYSA-N 3-amino-n-benzyl-5-nitro-n-phenylbenzenesulfonamide Chemical compound NC1=CC([N+]([O-])=O)=CC(S(=O)(=O)N(CC=2C=CC=CC=2)C=2C=CC=CC=2)=C1 RCMDDBWIELLOAV-UHFFFAOYSA-N 0.000 description 1
- OANNPXXJEXRQIJ-UHFFFAOYSA-N 3-amino-n-methyl-5-nitro-n-phenylbenzenesulfonamide Chemical compound C=1C(N)=CC([N+]([O-])=O)=CC=1S(=O)(=O)N(C)C1=CC=CC=C1 OANNPXXJEXRQIJ-UHFFFAOYSA-N 0.000 description 1
- KQIGMPWTAHJUMN-UHFFFAOYSA-N 3-aminopropane-1,2-diol Chemical compound NCC(O)CO KQIGMPWTAHJUMN-UHFFFAOYSA-N 0.000 description 1
- GWLFQPJKTXGLGD-UHFFFAOYSA-N 3-bromo-5-nitroaniline Chemical compound NC1=CC(Br)=CC([N+]([O-])=O)=C1 GWLFQPJKTXGLGD-UHFFFAOYSA-N 0.000 description 1
- CSPAHPDTERGHQG-UHFFFAOYSA-N 3-chloro-5-hydroxy-n-methyl-n-phenylbenzenesulfonamide Chemical compound C=1C(O)=CC(Cl)=CC=1S(=O)(=O)N(C)C1=CC=CC=C1 CSPAHPDTERGHQG-UHFFFAOYSA-N 0.000 description 1
- QKPIIZLKBAVAEP-UHFFFAOYSA-N 3-chloro-n-methyl-5-nitro-n-phenylbenzenesulfonamide Chemical compound C=1C(Cl)=CC([N+]([O-])=O)=CC=1S(=O)(=O)N(C)C1=CC=CC=C1 QKPIIZLKBAVAEP-UHFFFAOYSA-N 0.000 description 1
- HFWUJCMHBICSCV-UHFFFAOYSA-N 3-hydroxy-5-methoxy-n-methyl-n-phenylbenzenesulfonamide Chemical compound COC1=CC(O)=CC(S(=O)(=O)N(C)C=2C=CC=CC=2)=C1 HFWUJCMHBICSCV-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- AOKVYPFKQSAZGN-UHFFFAOYSA-N 3-methoxy-n-methyl-5-nitro-n-phenylbenzenesulfonamide Chemical compound COC1=CC([N+]([O-])=O)=CC(S(=O)(=O)N(C)C=2C=CC=CC=2)=C1 AOKVYPFKQSAZGN-UHFFFAOYSA-N 0.000 description 1
- DZIJEXQVMORGQX-UHFFFAOYSA-N 3-methyl-5-nitroaniline Chemical compound CC1=CC(N)=CC([N+]([O-])=O)=C1 DZIJEXQVMORGQX-UHFFFAOYSA-N 0.000 description 1
- LTVWXWWSCLXXAT-UHFFFAOYSA-N 3-nitro-5-(trifluoromethyl)aniline Chemical compound NC1=CC([N+]([O-])=O)=CC(C(F)(F)F)=C1 LTVWXWWSCLXXAT-UHFFFAOYSA-N 0.000 description 1
- JDIAMHNYAPDMRB-UHFFFAOYSA-N 3-nitro-5-(trifluoromethyl)phenol Chemical compound OC1=CC([N+]([O-])=O)=CC(C(F)(F)F)=C1 JDIAMHNYAPDMRB-UHFFFAOYSA-N 0.000 description 1
- XJCVRTZCHMZPBD-UHFFFAOYSA-N 3-nitroaniline Chemical compound NC1=CC=CC([N+]([O-])=O)=C1 XJCVRTZCHMZPBD-UHFFFAOYSA-N 0.000 description 1
- MWWNNNAOGWPTQY-UHFFFAOYSA-N 3-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=CC(S(Cl)(=O)=O)=C1 MWWNNNAOGWPTQY-UHFFFAOYSA-N 0.000 description 1
- RTZZCYNQPHTPPL-UHFFFAOYSA-N 3-nitrophenol Chemical compound OC1=CC=CC([N+]([O-])=O)=C1 RTZZCYNQPHTPPL-UHFFFAOYSA-N 0.000 description 1
- OZDCZHDOIBUGAJ-UHFFFAOYSA-N 4-(trifluoromethyl)benzenesulfonyl chloride Chemical compound FC(F)(F)C1=CC=C(S(Cl)(=O)=O)C=C1 OZDCZHDOIBUGAJ-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 1
- WRFYIYOXJWKONR-UHFFFAOYSA-N 4-bromo-2-methoxyaniline Chemical compound COC1=CC(Br)=CC=C1N WRFYIYOXJWKONR-UHFFFAOYSA-N 0.000 description 1
- ZLYBFBAHAQEEQQ-UHFFFAOYSA-N 4-chlorobenzenesulfonyl chloride Chemical compound ClC1=CC=C(S(Cl)(=O)=O)C=C1 ZLYBFBAHAQEEQQ-UHFFFAOYSA-N 0.000 description 1
- GPLXRIVINNIQFY-UHFFFAOYSA-N 4-methyl-n-(4-methylphenyl)benzenesulfonamide Chemical compound C1=CC(C)=CC=C1NS(=O)(=O)C1=CC=C(C)C=C1 GPLXRIVINNIQFY-UHFFFAOYSA-N 0.000 description 1
- FQVLOBQILLZLJA-UHFFFAOYSA-N 5-chlorobenzene-1,3-diol Chemical compound OC1=CC(O)=CC(Cl)=C1 FQVLOBQILLZLJA-UHFFFAOYSA-N 0.000 description 1
- MSFGJICDOLGZQK-UHFFFAOYSA-N 5-ethylbenzene-1,3-diol Chemical compound CCC1=CC(O)=CC(O)=C1 MSFGJICDOLGZQK-UHFFFAOYSA-N 0.000 description 1
- RRFBFXPWTWMKNU-UHFFFAOYSA-N 5-fluoro-2-methylbenzenesulfonamide;hydrochloride Chemical compound Cl.CC1=CC=C(F)C=C1S(N)(=O)=O RRFBFXPWTWMKNU-UHFFFAOYSA-N 0.000 description 1
- DSBIJCMXAIKKKI-UHFFFAOYSA-N 5-nitro-o-toluidine Chemical compound CC1=CC=C([N+]([O-])=O)C=C1N DSBIJCMXAIKKKI-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- QVNDPTUZLUVRIV-UHFFFAOYSA-N C(C)OC(CNC1=CC(=CC(=C1)C)N(CC1=CC=CC=C1)S(=O)(=O)C1=CC=CC=C1)=O Chemical compound C(C)OC(CNC1=CC(=CC(=C1)C)N(CC1=CC=CC=C1)S(=O)(=O)C1=CC=CC=C1)=O QVNDPTUZLUVRIV-UHFFFAOYSA-N 0.000 description 1
- AQQVVQGRGCQGTA-UHFFFAOYSA-N C(C)OC(CNC1=CC(=CC(=C1)[N+](=O)[O-])Br)=O Chemical compound C(C)OC(CNC1=CC(=CC(=C1)[N+](=O)[O-])Br)=O AQQVVQGRGCQGTA-UHFFFAOYSA-N 0.000 description 1
- BVSLURGKJHPOHV-UHFFFAOYSA-N C(C)OC(COC1=C(C=CC(=C1)NS(=O)(=O)C1=CC=CC=C1)C)=O Chemical compound C(C)OC(COC1=C(C=CC(=C1)NS(=O)(=O)C1=CC=CC=C1)C)=O BVSLURGKJHPOHV-UHFFFAOYSA-N 0.000 description 1
- SDNDJPPBWUPKDP-UHFFFAOYSA-N C(C)OC(COC1=C(C=CC(=C1)NS(=O)(=O)C1=CC=CC=C1)OC)=O Chemical compound C(C)OC(COC1=C(C=CC(=C1)NS(=O)(=O)C1=CC=CC=C1)OC)=O SDNDJPPBWUPKDP-UHFFFAOYSA-N 0.000 description 1
- RPKJOZDLIITTFY-UHFFFAOYSA-N C(C)OC(COC1=CC(=CC(=C1)C)N(C)S(=O)(=O)C1=C(C=CC=C1)Cl)=O Chemical compound C(C)OC(COC1=CC(=CC(=C1)C)N(C)S(=O)(=O)C1=C(C=CC=C1)Cl)=O RPKJOZDLIITTFY-UHFFFAOYSA-N 0.000 description 1
- NVXSJLWJQYCXAD-UHFFFAOYSA-N C(C)OC(COC1=CC(=CC(=C1)C)NS(=O)(=O)C1=C(C=CC=C1)Cl)=O Chemical compound C(C)OC(COC1=CC(=CC(=C1)C)NS(=O)(=O)C1=C(C=CC=C1)Cl)=O NVXSJLWJQYCXAD-UHFFFAOYSA-N 0.000 description 1
- ZZQGMDDCGTYVEO-UHFFFAOYSA-N C(C)OC(COC1=CC(=CC(=C1)C)OS(=O)(=O)C=1SC=CC1)=O Chemical compound C(C)OC(COC1=CC(=CC(=C1)C)OS(=O)(=O)C=1SC=CC1)=O ZZQGMDDCGTYVEO-UHFFFAOYSA-N 0.000 description 1
- IPYRNFHGVRYFKX-UHFFFAOYSA-N C(C)OC(COC1=CC(=CC(=C1)CC)OS(=O)(=O)C1=CC=CC=C1)=O Chemical compound C(C)OC(COC1=CC(=CC(=C1)CC)OS(=O)(=O)C1=CC=CC=C1)=O IPYRNFHGVRYFKX-UHFFFAOYSA-N 0.000 description 1
- LGSUUNPBJUOOET-UHFFFAOYSA-N C(C)OC(COC1=CC(=CC(=C1)OC)NC(C)=O)=O Chemical compound C(C)OC(COC1=CC(=CC(=C1)OC)NC(C)=O)=O LGSUUNPBJUOOET-UHFFFAOYSA-N 0.000 description 1
- HTJPSVLIVNICCB-UHFFFAOYSA-N C(C)OC(COC1=CC(=CC(=C1)OS(=O)(=O)C1=C(C=CC=C1)Cl)Cl)=O Chemical compound C(C)OC(COC1=CC(=CC(=C1)OS(=O)(=O)C1=C(C=CC=C1)Cl)Cl)=O HTJPSVLIVNICCB-UHFFFAOYSA-N 0.000 description 1
- OJMZHFWZOWEMHN-UHFFFAOYSA-N C(C)OC(COC1=CC(=CC(=C1)OS(=O)(=O)C1=CC=CC=C1)Cl)=O Chemical compound C(C)OC(COC1=CC(=CC(=C1)OS(=O)(=O)C1=CC=CC=C1)Cl)=O OJMZHFWZOWEMHN-UHFFFAOYSA-N 0.000 description 1
- OPXGCKIMHJWHGY-UHFFFAOYSA-N C(C)OC(COC1=CC(=CC(=C1)S(N(C1=CC=CC=C1)C)(=O)=O)Cl)=O Chemical compound C(C)OC(COC1=CC(=CC(=C1)S(N(C1=CC=CC=C1)C)(=O)=O)Cl)=O OPXGCKIMHJWHGY-UHFFFAOYSA-N 0.000 description 1
- VVJRVLUVGWFGNM-UHFFFAOYSA-N C(C1=CC=CC=C1)OC(COC1=CC(=CC(=C1)C)O)=O Chemical compound C(C1=CC=CC=C1)OC(COC1=CC(=CC(=C1)C)O)=O VVJRVLUVGWFGNM-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- RENMDAKOXSCIGH-UHFFFAOYSA-N Chloroacetonitrile Chemical compound ClCC#N RENMDAKOXSCIGH-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- UENWUQNYQSKPNY-UHFFFAOYSA-N ClC=1C=C(OCC(=O)O)C=C(C1)N(C)S(=O)(=O)C1=CC=CC=C1 Chemical compound ClC=1C=C(OCC(=O)O)C=C(C1)N(C)S(=O)(=O)C1=CC=CC=C1 UENWUQNYQSKPNY-UHFFFAOYSA-N 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 108010014173 Factor X Proteins 0.000 description 1
- 108010000196 Factor XIIIa Proteins 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 108010080798 N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide Proteins 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- JCKKTDYHOLOXSL-UHFFFAOYSA-N N-[2-(3-aminophenoxy)ethyl]-N-benzyl-2,3,5,6-tetrachloropyridin-4-amine Chemical compound C(C1=CC=CC=C1)N(CCOC1=CC(=CC=C1)N)C1=C(C(=NC(=C1Cl)Cl)Cl)Cl JCKKTDYHOLOXSL-UHFFFAOYSA-N 0.000 description 1
- XIACGSOVXFXPGK-UHFFFAOYSA-N N-[3-methyl-5-[2-(pyridin-4-ylamino)ethoxy]phenyl]-3-(2-morpholin-4-yl-2-oxoethoxy)benzenesulfonamide Chemical compound CC=1C=C(C=C(C1)OCCNC1=CC=NC=C1)NS(=O)(=O)C=1C=C(OCC(=O)N2CCOCC2)C=CC1 XIACGSOVXFXPGK-UHFFFAOYSA-N 0.000 description 1
- XLOIOZVNENLVDX-UHFFFAOYSA-N N-benzyl-2,3,5,6-tetrachloro-N-[2-(3-nitrophenoxy)ethyl]pyridin-4-amine Chemical compound C(C1=CC=CC=C1)N(CCOC1=CC(=CC=C1)[N+](=O)[O-])C1=C(C(=NC(=C1Cl)Cl)Cl)Cl XLOIOZVNENLVDX-UHFFFAOYSA-N 0.000 description 1
- CMSXXTADAKPZKO-UHFFFAOYSA-N N1=CC=C(C=C1)NC(COC1=CC(=CC(=C1)C)OS(=O)(=O)C1=C(C=CC=C1)C(=O)OCC1=CC=CC=C1)=O Chemical compound N1=CC=C(C=C1)NC(COC1=CC(=CC(=C1)C)OS(=O)(=O)C1=C(C=CC=C1)C(=O)OCC1=CC=CC=C1)=O CMSXXTADAKPZKO-UHFFFAOYSA-N 0.000 description 1
- RAOSMJXNDRNVFH-UHFFFAOYSA-N N1=CC=C(C=C1)NC(COC1=CC(=CC(=C1)S(N(C1=CC=CC=C1)CC1=CC=CC=C1)(=O)=O)Cl)=O Chemical compound N1=CC=C(C=C1)NC(COC1=CC(=CC(=C1)S(N(C1=CC=CC=C1)CC1=CC=CC=C1)(=O)=O)Cl)=O RAOSMJXNDRNVFH-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 102100038124 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical compound C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 description 1
- 101000712605 Theromyzon tessulatum Theromin Proteins 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- IPPPTVWRLXXWAH-UHFFFAOYSA-N [3-(1,3-dioxoisoindol-2-yl)-5-methylphenyl] benzenesulfonate Chemical compound C=1C(N2C(C3=CC=CC=C3C2=O)=O)=CC(C)=CC=1OS(=O)(=O)C1=CC=CC=C1 IPPPTVWRLXXWAH-UHFFFAOYSA-N 0.000 description 1
- CPUMZZXQLFNADP-UHFFFAOYSA-N [3-[2-oxo-2-(pyridin-4-ylamino)ethoxy]phenyl] benzenesulfonate Chemical compound C=1C=NC=CC=1NC(=O)COC(C=1)=CC=CC=1OS(=O)(=O)C1=CC=CC=C1 CPUMZZXQLFNADP-UHFFFAOYSA-N 0.000 description 1
- NCEZWVJBQNFMDM-UHFFFAOYSA-N [3-chloro-5-[2-oxo-2-(pyridin-4-ylamino)ethoxy]phenyl] 2-chlorobenzenesulfonate Chemical compound C=1C(OS(=O)(=O)C=2C(=CC=CC=2)Cl)=CC(Cl)=CC=1OCC(=O)NC1=CC=NC=C1 NCEZWVJBQNFMDM-UHFFFAOYSA-N 0.000 description 1
- FOAFIWQVDZFALZ-UHFFFAOYSA-N [3-chloro-5-[2-oxo-2-(pyridin-4-ylamino)ethoxy]phenyl] benzenesulfonate Chemical compound C=1C(OS(=O)(=O)C=2C=CC=CC=2)=CC(Cl)=CC=1OCC(=O)NC1=CC=NC=C1 FOAFIWQVDZFALZ-UHFFFAOYSA-N 0.000 description 1
- BYUMHYVADKLIFF-UHFFFAOYSA-N [3-ethyl-5-[2-oxo-2-(pyridin-4-ylamino)ethoxy]phenyl] benzenesulfonate Chemical compound C=1C(OS(=O)(=O)C=2C=CC=CC=2)=CC(CC)=CC=1OCC(=O)NC1=CC=NC=C1 BYUMHYVADKLIFF-UHFFFAOYSA-N 0.000 description 1
- RUHLFOYOSNLHQI-UHFFFAOYSA-N [3-methyl-5-[(4-methylphenyl)sulfonylamino]phenyl] benzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=CC(C)=CC(OS(=O)(=O)C=2C=CC=CC=2)=C1 RUHLFOYOSNLHQI-UHFFFAOYSA-N 0.000 description 1
- CIOFZLSALROPCE-UHFFFAOYSA-N [3-methyl-5-[2-(pyridin-4-ylamino)ethoxy]phenyl] 3-[2-(2-hydroxyethylamino)-2-oxoethoxy]benzenesulfonate Chemical compound C=1C(OS(=O)(=O)C=2C=C(OCC(=O)NCCO)C=CC=2)=CC(C)=CC=1OCCNC1=CC=NC=C1 CIOFZLSALROPCE-UHFFFAOYSA-N 0.000 description 1
- ULSZQYMAIFKAAH-UHFFFAOYSA-N [3-methyl-5-[2-[methyl(pyridin-4-yl)amino]-2-oxoethoxy]phenyl] 2-chlorobenzenesulfonate Chemical compound C=1C=NC=CC=1N(C)C(=O)COC(C=1)=CC(C)=CC=1OS(=O)(=O)C1=CC=CC=C1Cl ULSZQYMAIFKAAH-UHFFFAOYSA-N 0.000 description 1
- DMQXVSUFDPJZLA-UHFFFAOYSA-N [3-methyl-5-[2-oxo-2-(pyridin-4-ylamino)ethoxy]phenyl] 2-methoxybenzenesulfonate Chemical compound COC1=CC=CC=C1S(=O)(=O)OC1=CC(C)=CC(OCC(=O)NC=2C=CN=CC=2)=C1 DMQXVSUFDPJZLA-UHFFFAOYSA-N 0.000 description 1
- CBQUZZFVEFZYTD-UHFFFAOYSA-N [3-methyl-5-[2-oxo-2-(pyridin-4-ylamino)ethoxy]phenyl] 2-methylbenzenesulfonate Chemical compound C=1C(OS(=O)(=O)C=2C(=CC=CC=2)C)=CC(C)=CC=1OCC(=O)NC1=CC=NC=C1 CBQUZZFVEFZYTD-UHFFFAOYSA-N 0.000 description 1
- HHYUVNYVVGJFQX-UHFFFAOYSA-N [3-methyl-5-[2-oxo-2-(pyridin-4-ylamino)ethoxy]phenyl] 2-nitrobenzenesulfonate Chemical compound C=1C(OS(=O)(=O)C=2C(=CC=CC=2)[N+]([O-])=O)=CC(C)=CC=1OCC(=O)NC1=CC=NC=C1 HHYUVNYVVGJFQX-UHFFFAOYSA-N 0.000 description 1
- SXSHJCIWKUUXAD-UHFFFAOYSA-N [3-methyl-5-[2-oxo-2-(pyridin-4-ylamino)ethoxy]phenyl] benzenesulfonate Chemical compound C=1C(OS(=O)(=O)C=2C=CC=CC=2)=CC(C)=CC=1OCC(=O)NC1=CC=NC=C1 SXSHJCIWKUUXAD-UHFFFAOYSA-N 0.000 description 1
- UTRRLKTUUKPCQO-UHFFFAOYSA-N [3-methyl-5-[2-oxo-2-(pyridin-4-ylamino)ethoxy]phenyl] thiophene-2-sulfonate Chemical compound C=1C(OS(=O)(=O)C=2SC=CC=2)=CC(C)=CC=1OCC(=O)NC1=CC=NC=C1 UTRRLKTUUKPCQO-UHFFFAOYSA-N 0.000 description 1
- BAGJPSDIMPUGTF-UHFFFAOYSA-N [O-][N+](C1=CC=CC([N+]([O-])=O)=C1)=O.F.F.F Chemical compound [O-][N+](C1=CC=CC([N+]([O-])=O)=C1)=O.F.F.F BAGJPSDIMPUGTF-UHFFFAOYSA-N 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- 125000005336 allyloxy group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000005097 aminocarbonylalkyl group Chemical group 0.000 description 1
- 150000003927 aminopyridines Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 1
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical group C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 1
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- WPFALVXBVAPMAU-UHFFFAOYSA-N benzyl 2-[3-(benzenesulfonyloxy)-5-methylphenoxy]acetate Chemical compound C(C1=CC=CC=C1)OC(COC1=CC(=CC(=C1)C)OS(=O)(=O)C1=CC=CC=C1)=O WPFALVXBVAPMAU-UHFFFAOYSA-N 0.000 description 1
- JHVLLYQQQYIWKX-UHFFFAOYSA-N benzyl 2-bromoacetate Chemical compound BrCC(=O)OCC1=CC=CC=C1 JHVLLYQQQYIWKX-UHFFFAOYSA-N 0.000 description 1
- VWEFHTQEDKCERN-UHFFFAOYSA-N benzyl 2-chlorosulfonylbenzoate Chemical compound ClS(=O)(=O)C1=CC=CC=C1C(=O)OCC1=CC=CC=C1 VWEFHTQEDKCERN-UHFFFAOYSA-N 0.000 description 1
- NBLAIKHFQBOVPV-UHFFFAOYSA-N bis(ethoxycarbonyl)azaniumylideneazanide Chemical compound CCOC(=O)[N+](=[N-])C(=O)OCC NBLAIKHFQBOVPV-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical class B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 1
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- MPTQRFCYZCXJFQ-UHFFFAOYSA-L copper(II) chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Cu+2] MPTQRFCYZCXJFQ-UHFFFAOYSA-L 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- MJWVCJUSRGLHFO-UHFFFAOYSA-N cyclohexanesulfonyl chloride Chemical compound ClS(=O)(=O)C1CCCCC1 MJWVCJUSRGLHFO-UHFFFAOYSA-N 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000005695 dehalogenation reaction Methods 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- OCAWWNOXXYVZTM-UHFFFAOYSA-N ethyl 2-(2-methoxy-5-nitrophenoxy)acetate Chemical compound CCOC(=O)COC1=CC([N+]([O-])=O)=CC=C1OC OCAWWNOXXYVZTM-UHFFFAOYSA-N 0.000 description 1
- BSGTXGMJLVXCMB-UHFFFAOYSA-N ethyl 2-(3-aminophenoxy)-2-methylpropanoate Chemical compound CCOC(=O)C(C)(C)OC1=CC=CC(N)=C1 BSGTXGMJLVXCMB-UHFFFAOYSA-N 0.000 description 1
- FQSVBZHXZYHTII-UHFFFAOYSA-N ethyl 2-(3-hydroxy-5-methylphenoxy)acetate Chemical compound CCOC(=O)COC1=CC(C)=CC(O)=C1 FQSVBZHXZYHTII-UHFFFAOYSA-N 0.000 description 1
- XAMCZJDBFKSXED-UHFFFAOYSA-N ethyl 2-(5-amino-2-methoxyphenoxy)acetate Chemical compound CCOC(=O)COC1=CC(N)=CC=C1OC XAMCZJDBFKSXED-UHFFFAOYSA-N 0.000 description 1
- KDOMPOBZRDXPJL-UHFFFAOYSA-N ethyl 2-(5-amino-2-methylphenoxy)acetate Chemical compound CCOC(=O)COC1=CC(N)=CC=C1C KDOMPOBZRDXPJL-UHFFFAOYSA-N 0.000 description 1
- MKYDTCMZYPTLFV-UHFFFAOYSA-N ethyl 2-[3-(benzenesulfonamido)-5-methylphenoxy]acetate Chemical compound CCOC(=O)COC1=CC(C)=CC(NS(=O)(=O)C=2C=CC=CC=2)=C1 MKYDTCMZYPTLFV-UHFFFAOYSA-N 0.000 description 1
- TVMLHSHUDCZPDX-UHFFFAOYSA-N ethyl 2-[3-(benzenesulfonamido)phenoxy]-2-methylpropanoate Chemical compound CCOC(=O)C(C)(C)OC1=CC=CC(NS(=O)(=O)C=2C=CC=CC=2)=C1 TVMLHSHUDCZPDX-UHFFFAOYSA-N 0.000 description 1
- GTXYWNZPWHQSKH-UHFFFAOYSA-N ethyl 2-[3-(benzenesulfonamido)phenoxy]propanoate Chemical compound CCOC(=O)C(C)OC1=CC=CC(NS(=O)(=O)C=2C=CC=CC=2)=C1 GTXYWNZPWHQSKH-UHFFFAOYSA-N 0.000 description 1
- COYHCDHWOYBQFH-UHFFFAOYSA-N ethyl 2-[3-(benzenesulfonyloxy)-5-methyl-N-(4-methylphenyl)sulfonylanilino]acetate Chemical compound C(C)OC(CN(C1=CC(=CC(=C1)C)OS(=O)(=O)C1=CC=CC=C1)S(=O)(=O)C1=CC=C(C=C1)C)=O COYHCDHWOYBQFH-UHFFFAOYSA-N 0.000 description 1
- MRQQZGUQMILMPS-UHFFFAOYSA-N ethyl 2-[3-(benzenesulfonyloxy)anilino]acetate Chemical compound C(C)OC(CNC1=CC(=CC=C1)OS(=O)(=O)C1=CC=CC=C1)=O MRQQZGUQMILMPS-UHFFFAOYSA-N 0.000 description 1
- QMBCWXPDURHRKW-UHFFFAOYSA-N ethyl 2-[3-(cyclohexylsulfonylamino)phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(NS(=O)(=O)C2CCCCC2)=C1 QMBCWXPDURHRKW-UHFFFAOYSA-N 0.000 description 1
- RWIATBKXCKWSTQ-UHFFFAOYSA-N ethyl 2-[3-(naphthalen-1-ylsulfonylamino)phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(NS(=O)(=O)C=2C3=CC=CC=C3C=CC=2)=C1 RWIATBKXCKWSTQ-UHFFFAOYSA-N 0.000 description 1
- JKCCCAFUXLVLHU-UHFFFAOYSA-N ethyl 2-[3-(naphthalen-2-ylsulfonylamino)phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(NS(=O)(=O)C=2C=C3C=CC=CC3=CC=2)=C1 JKCCCAFUXLVLHU-UHFFFAOYSA-N 0.000 description 1
- YFRXMYABJCSJDT-UHFFFAOYSA-N ethyl 2-[3-[(4-methylphenyl)sulfonylamino]phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(NS(=O)(=O)C=2C=CC(C)=CC=2)=C1 YFRXMYABJCSJDT-UHFFFAOYSA-N 0.000 description 1
- HJMCDRUDBZIKQF-UHFFFAOYSA-N ethyl 2-[3-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(NS(=O)(=O)C=2C=C(C=CC=2)C(F)(F)F)=C1 HJMCDRUDBZIKQF-UHFFFAOYSA-N 0.000 description 1
- VILBSTCQGHEZGV-UHFFFAOYSA-N ethyl 2-[3-[[4-(trifluoromethyl)phenyl]sulfonylamino]phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(NS(=O)(=O)C=2C=CC(=CC=2)C(F)(F)F)=C1 VILBSTCQGHEZGV-UHFFFAOYSA-N 0.000 description 1
- DTIIBXOAGSIKII-UHFFFAOYSA-N ethyl 2-[3-[benzenesulfonyl(benzyl)amino]-5-chlorophenoxy]acetate Chemical compound C(C)OC(COC1=CC(=CC(=C1)N(CC1=CC=CC=C1)S(=O)(=O)C1=CC=CC=C1)Cl)=O DTIIBXOAGSIKII-UHFFFAOYSA-N 0.000 description 1
- VTVRMKHNEGENLL-UHFFFAOYSA-N ethyl 2-[3-[benzenesulfonyl(benzyl)amino]phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(N(CC=2C=CC=CC=2)S(=O)(=O)C=2C=CC=CC=2)=C1 VTVRMKHNEGENLL-UHFFFAOYSA-N 0.000 description 1
- UBDXDOFHIJNUOH-UHFFFAOYSA-N ethyl 2-[3-[benzenesulfonyl(ethyl)amino]phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(N(CC)S(=O)(=O)C=2C=CC=CC=2)=C1 UBDXDOFHIJNUOH-UHFFFAOYSA-N 0.000 description 1
- RDGWKDQDWWPHBY-UHFFFAOYSA-N ethyl 2-[3-[benzenesulfonyl(methyl)amino]-5-chlorophenoxy]acetate Chemical compound C(C)OC(COC1=CC(=CC(=C1)N(C)S(=O)(=O)C1=CC=CC=C1)Cl)=O RDGWKDQDWWPHBY-UHFFFAOYSA-N 0.000 description 1
- MRFRWWPAHJVIKD-UHFFFAOYSA-N ethyl 2-[3-[benzenesulfonyl(methyl)amino]-5-methoxyphenoxy]acetate Chemical compound C(C)OC(COC1=CC(=CC(=C1)N(C)S(=O)(=O)C1=CC=CC=C1)OC)=O MRFRWWPAHJVIKD-UHFFFAOYSA-N 0.000 description 1
- QJMXFDNYKPVWRD-UHFFFAOYSA-N ethyl 2-[3-[benzenesulfonyl(methyl)amino]phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC(N(C)S(=O)(=O)C=2C=CC=CC=2)=C1 QJMXFDNYKPVWRD-UHFFFAOYSA-N 0.000 description 1
- WJEACMFYAPODCN-UHFFFAOYSA-N ethyl 2-[3-[benzenesulfonyl(propyl)amino]phenoxy]acetate Chemical compound C=1C=CC=CC=1S(=O)(=O)N(CCC)C1=CC=CC(OCC(=O)OCC)=C1 WJEACMFYAPODCN-UHFFFAOYSA-N 0.000 description 1
- LKAUJBGREXQLPE-UHFFFAOYSA-N ethyl 2-[3-[benzyl(phenyl)sulfamoyl]-5-chloroanilino]acetate Chemical compound C(C)OC(CNC1=CC(=CC(=C1)S(N(C1=CC=CC=C1)CC1=CC=CC=C1)(=O)=O)Cl)=O LKAUJBGREXQLPE-UHFFFAOYSA-N 0.000 description 1
- BXXHHEYWRRDOPE-UHFFFAOYSA-N ethyl 2-[3-[benzyl(phenyl)sulfamoyl]-5-chlorophenoxy]acetate Chemical compound C(C)OC(COC1=CC(=CC(=C1)S(N(C1=CC=CC=C1)CC1=CC=CC=C1)(=O)=O)Cl)=O BXXHHEYWRRDOPE-UHFFFAOYSA-N 0.000 description 1
- GZPPKFDLULLCDI-UHFFFAOYSA-N ethyl 2-[3-[benzyl(phenyl)sulfamoyl]-5-methoxyphenoxy]acetate Chemical compound C(C)OC(COC1=CC(=CC(=C1)S(N(C1=CC=CC=C1)CC1=CC=CC=C1)(=O)=O)OC)=O GZPPKFDLULLCDI-UHFFFAOYSA-N 0.000 description 1
- AUHCBHIZRTZFEP-UHFFFAOYSA-N ethyl 2-[3-methoxy-5-[methyl(phenyl)sulfamoyl]phenoxy]acetate Chemical compound C(C)OC(COC1=CC(=CC(=C1)S(N(C1=CC=CC=C1)C)(=O)=O)OC)=O AUHCBHIZRTZFEP-UHFFFAOYSA-N 0.000 description 1
- BVPNVLGZNQKDME-UHFFFAOYSA-N ethyl 2-[N-(2-methoxyphenyl)sulfonyl-3-methyl-5-[2-(pyridin-4-ylamino)ethoxy]anilino]acetate Chemical compound C(C)OC(CN(C1=CC(=CC(=C1)OCCNC1=CC=NC=C1)C)S(=O)(=O)C1=C(C=CC=C1)OC)=O BVPNVLGZNQKDME-UHFFFAOYSA-N 0.000 description 1
- OKFINYLQIUZXCP-UHFFFAOYSA-N ethyl 2-[N-(benzenesulfonyl)-3-[2-[benzyl-(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]-5-methylanilino]acetate Chemical compound C(C)OC(CN(C1=CC(=CC(=C1)OCCN(C1=C(C(=NC(=C1Cl)Cl)Cl)Cl)CC1=CC=CC=C1)C)S(=O)(=O)C1=CC=CC=C1)=O OKFINYLQIUZXCP-UHFFFAOYSA-N 0.000 description 1
- AHMOCQJEUQBCPT-UHFFFAOYSA-N ethyl 2-[N-(benzenesulfonyl)-3-methyl-5-[2-[(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]anilino]acetate Chemical compound C(C)OC(CN(C1=CC(=CC(=C1)OCCNC1=C(C(=NC(=C1Cl)Cl)Cl)Cl)C)S(=O)(=O)C1=CC=CC=C1)=O AHMOCQJEUQBCPT-UHFFFAOYSA-N 0.000 description 1
- LUAHRBXBMRQGIX-UHFFFAOYSA-N ethyl 2-amino-2-(3-nitrophenyl)acetate Chemical compound CCOC(=O)C(N)C1=CC=CC([N+]([O-])=O)=C1 LUAHRBXBMRQGIX-UHFFFAOYSA-N 0.000 description 1
- XBPOBCXHALHJFP-UHFFFAOYSA-N ethyl 4-bromobutanoate Chemical compound CCOC(=O)CCCBr XBPOBCXHALHJFP-UHFFFAOYSA-N 0.000 description 1
- KLKMYAVMMKDPLO-UHFFFAOYSA-N ethyl 5-[n-(benzenesulfonyl)-3-[2-[benzyl-(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]-5-methylanilino]pentanoate Chemical compound C=1C=CC=CC=1S(=O)(=O)N(CCCCC(=O)OCC)C(C=1)=CC(C)=CC=1OCCN(C=1C(=C(Cl)N=C(Cl)C=1Cl)Cl)CC1=CC=CC=C1 KLKMYAVMMKDPLO-UHFFFAOYSA-N 0.000 description 1
- UBKKKOAHBLNXCV-UHFFFAOYSA-N ethyl 5-[n-(benzenesulfonyl)-3-methyl-5-[2-[(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]anilino]pentanoate Chemical compound C=1C=CC=CC=1S(=O)(=O)N(CCCCC(=O)OCC)C(C=1)=CC(C)=CC=1OCCNC1=C(Cl)C(Cl)=NC(Cl)=C1Cl UBKKKOAHBLNXCV-UHFFFAOYSA-N 0.000 description 1
- AFRWBGJRWRHQOV-UHFFFAOYSA-N ethyl 5-bromopentanoate Chemical compound CCOC(=O)CCCCBr AFRWBGJRWRHQOV-UHFFFAOYSA-N 0.000 description 1
- ZZTUSAWHUZBLHK-UHFFFAOYSA-N ethyl 6-[n-(benzenesulfonyl)-3-methyl-5-[2-[(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]anilino]hexanoate Chemical compound C=1C=CC=CC=1S(=O)(=O)N(CCCCCC(=O)OCC)C(C=1)=CC(C)=CC=1OCCNC1=C(Cl)C(Cl)=NC(Cl)=C1Cl ZZTUSAWHUZBLHK-UHFFFAOYSA-N 0.000 description 1
- DXBULVYHTICWKT-UHFFFAOYSA-N ethyl 6-bromohexanoate Chemical compound CCOC(=O)CCCCCBr DXBULVYHTICWKT-UHFFFAOYSA-N 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- CBINMIGLYFRYRS-UHFFFAOYSA-N ethyl n-[3-[2-[benzyl-(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]-5-methylphenyl]-n-(2-methoxyphenyl)sulfonylcarbamate Chemical compound C=1C=CC=C(OC)C=1S(=O)(=O)N(C(=O)OCC)C(C=1)=CC(C)=CC=1OCCN(C=1C(=C(Cl)N=C(Cl)C=1Cl)Cl)CC1=CC=CC=C1 CBINMIGLYFRYRS-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 108010069898 fibrinogen fragment X Proteins 0.000 description 1
- HDVRLUFGYQYLFJ-UHFFFAOYSA-N flamenol Chemical compound COC1=CC(O)=CC(O)=C1 HDVRLUFGYQYLFJ-UHFFFAOYSA-N 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 210000004276 hyalin Anatomy 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- JBFYUZGYRGXSFL-UHFFFAOYSA-N imidazolide Chemical compound C1=C[N-]C=N1 JBFYUZGYRGXSFL-UHFFFAOYSA-N 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- GSYFKPSPTSCNGG-UHFFFAOYSA-N methyl 2-(3-amino-5-methoxyphenoxy)acetate Chemical compound COC(COC1=CC(=CC(=C1)OC)N)=O GSYFKPSPTSCNGG-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- RRESNXHZDONYDZ-UHFFFAOYSA-N n-(3,5-dinitrophenyl)-n-methylbenzenesulfonamide Chemical compound C=1C=CC=CC=1S(=O)(=O)N(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1 RRESNXHZDONYDZ-UHFFFAOYSA-N 0.000 description 1
- ZXERTWPNZJETAC-UHFFFAOYSA-N n-(3,5-dinitrophenyl)acetamide Chemical compound CC(=O)NC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1 ZXERTWPNZJETAC-UHFFFAOYSA-N 0.000 description 1
- GPVKNODZFVGIGN-UHFFFAOYSA-N n-(3,5-dinitrophenyl)benzenesulfonamide Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC(NS(=O)(=O)C=2C=CC=CC=2)=C1 GPVKNODZFVGIGN-UHFFFAOYSA-N 0.000 description 1
- LBROZJGGODOXQU-UHFFFAOYSA-N n-(3-amino-5-chlorophenyl)-n-benzylbenzenesulfonamide Chemical compound NC1=CC(Cl)=CC(N(CC=2C=CC=CC=2)S(=O)(=O)C=2C=CC=CC=2)=C1 LBROZJGGODOXQU-UHFFFAOYSA-N 0.000 description 1
- SUSZPSPHAYNFGF-UHFFFAOYSA-N n-(3-amino-5-chlorophenyl)-n-methylbenzenesulfonamide Chemical compound C=1C=CC=CC=1S(=O)(=O)N(C)C1=CC(N)=CC(Cl)=C1 SUSZPSPHAYNFGF-UHFFFAOYSA-N 0.000 description 1
- XMEAZRNYQHVNNN-UHFFFAOYSA-N n-(3-amino-5-methoxyphenyl)-n-methylbenzenesulfonamide Chemical compound COC1=CC(N)=CC(N(C)S(=O)(=O)C=2C=CC=CC=2)=C1 XMEAZRNYQHVNNN-UHFFFAOYSA-N 0.000 description 1
- VUBIQLNKFIUBGD-UHFFFAOYSA-N n-(3-amino-5-methylphenyl)-n-benzylbenzenesulfonamide Chemical compound CC1=CC(N)=CC(N(CC=2C=CC=CC=2)S(=O)(=O)C=2C=CC=CC=2)=C1 VUBIQLNKFIUBGD-UHFFFAOYSA-N 0.000 description 1
- ASXSTLFMHSIMCV-UHFFFAOYSA-N n-(3-amino-5-nitrophenyl)-n-benzylbenzenesulfonamide Chemical compound [O-][N+](=O)C1=CC(N)=CC(N(CC=2C=CC=CC=2)S(=O)(=O)C=2C=CC=CC=2)=C1 ASXSTLFMHSIMCV-UHFFFAOYSA-N 0.000 description 1
- VLVWYPVORDFCIZ-UHFFFAOYSA-N n-(3-chloro-5-nitrophenyl)-n-methylbenzenesulfonamide Chemical compound C=1C=CC=CC=1S(=O)(=O)N(C)C1=CC(Cl)=CC([N+]([O-])=O)=C1 VLVWYPVORDFCIZ-UHFFFAOYSA-N 0.000 description 1
- QMGOLQZSRHZROM-UHFFFAOYSA-N n-(3-hydroxy-5-methoxyphenyl)-n-methylbenzenesulfonamide Chemical compound COC1=CC(O)=CC(N(C)S(=O)(=O)C=2C=CC=CC=2)=C1 QMGOLQZSRHZROM-UHFFFAOYSA-N 0.000 description 1
- WAXIIQHDNJOULR-UHFFFAOYSA-N n-(3-hydroxy-5-methoxyphenyl)acetamide Chemical compound COC1=CC(O)=CC(NC(C)=O)=C1 WAXIIQHDNJOULR-UHFFFAOYSA-N 0.000 description 1
- IXOPNRCTNNGZDH-UHFFFAOYSA-N n-(3-hydroxy-5-nitrophenyl)-n-methylbenzenesulfonamide Chemical compound C=1C=CC=CC=1S(=O)(=O)N(C)C1=CC(O)=CC([N+]([O-])=O)=C1 IXOPNRCTNNGZDH-UHFFFAOYSA-N 0.000 description 1
- IHCWVTVBURBZQX-UHFFFAOYSA-N n-(3-methoxy-5-nitrophenyl)-n-methylbenzenesulfonamide Chemical compound [O-][N+](=O)C1=CC(OC)=CC(N(C)S(=O)(=O)C=2C=CC=CC=2)=C1 IHCWVTVBURBZQX-UHFFFAOYSA-N 0.000 description 1
- XJRDVWSNEKUXDI-UHFFFAOYSA-N n-(3-methyl-5-nitrophenyl)benzenesulfonamide Chemical compound [O-][N+](=O)C1=CC(C)=CC(NS(=O)(=O)C=2C=CC=CC=2)=C1 XJRDVWSNEKUXDI-UHFFFAOYSA-N 0.000 description 1
- AJHSZNQWRYLSKR-UHFFFAOYSA-N n-(cyanomethyl)-2-methoxy-n-[3-methyl-5-[2-[(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]phenyl]benzenesulfonamide Chemical compound COC1=CC=CC=C1S(=O)(=O)N(CC#N)C1=CC(C)=CC(OCCNC=2C(=C(Cl)N=C(Cl)C=2Cl)Cl)=C1 AJHSZNQWRYLSKR-UHFFFAOYSA-N 0.000 description 1
- MTFOFTZZGKRPPP-UHFFFAOYSA-N n-[2-(3-amino-5-methylphenoxy)ethyl]pyridin-4-amine Chemical compound CC1=CC(N)=CC(OCCNC=2C=CN=CC=2)=C1 MTFOFTZZGKRPPP-UHFFFAOYSA-N 0.000 description 1
- DUEYYUQAYMNTSQ-UHFFFAOYSA-N n-[2-[3-amino-5-(trifluoromethyl)phenoxy]ethyl]-2,3,5,6-tetrachloropyridin-4-amine Chemical compound FC(F)(F)C1=CC(N)=CC(OCCNC=2C(=C(Cl)N=C(Cl)C=2Cl)Cl)=C1 DUEYYUQAYMNTSQ-UHFFFAOYSA-N 0.000 description 1
- NDTGEFYTMFBFDQ-UHFFFAOYSA-N n-[3-[2-[(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]-5-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound C=1C(OCCNC=2C(=C(Cl)N=C(Cl)C=2Cl)Cl)=CC(C(F)(F)F)=CC=1NS(=O)(=O)C1=CC=CC=C1 NDTGEFYTMFBFDQ-UHFFFAOYSA-N 0.000 description 1
- LDFDUIQODCQDEP-UHFFFAOYSA-N n-[3-[2-[benzyl-(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]-5-methylphenyl]-n-(cyanomethyl)-2-methoxybenzenesulfonamide Chemical compound COC1=CC=CC=C1S(=O)(=O)N(CC#N)C1=CC(C)=CC(OCCN(CC=2C=CC=CC=2)C=2C(=C(Cl)N=C(Cl)C=2Cl)Cl)=C1 LDFDUIQODCQDEP-UHFFFAOYSA-N 0.000 description 1
- HDUILGKGCFSVRB-UHFFFAOYSA-N n-[3-[2-[benzyl-(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]-5-methylphenyl]benzenesulfonamide Chemical compound C=1C(OCCN(CC=2C=CC=CC=2)C=2C(=C(Cl)N=C(Cl)C=2Cl)Cl)=CC(C)=CC=1NS(=O)(=O)C1=CC=CC=C1 HDUILGKGCFSVRB-UHFFFAOYSA-N 0.000 description 1
- LPBOGZQPEIAKAT-UHFFFAOYSA-N n-[3-[2-[benzyl-(2,3,5,6-tetrachloropyridin-4-yl)amino]ethoxy]phenyl]benzenesulfonamide Chemical compound ClC1=NC(Cl)=C(Cl)C(N(CCOC=2C=C(NS(=O)(=O)C=3C=CC=CC=3)C=CC=2)CC=2C=CC=CC=2)=C1Cl LPBOGZQPEIAKAT-UHFFFAOYSA-N 0.000 description 1
- PMQCAJONQLHSMS-UHFFFAOYSA-N n-[3-cyano-5-[2-(pyridin-4-ylamino)ethoxy]phenyl]benzenesulfonamide Chemical compound C=1C=CC=CC=1S(=O)(=O)NC(C=C(C=1)C#N)=CC=1OCCNC1=CC=NC=C1 PMQCAJONQLHSMS-UHFFFAOYSA-N 0.000 description 1
- BALLEAZCYYCPQK-UHFFFAOYSA-N n-benzyl-3-chloro-5-hydroxy-n-phenylbenzenesulfonamide Chemical compound OC1=CC(Cl)=CC(S(=O)(=O)N(CC=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BALLEAZCYYCPQK-UHFFFAOYSA-N 0.000 description 1
- RAYLNUXJFMKJSI-UHFFFAOYSA-N n-benzyl-3-chloro-5-nitro-n-phenylbenzenesulfonamide Chemical compound [O-][N+](=O)C1=CC(Cl)=CC(S(=O)(=O)N(CC=2C=CC=CC=2)C=2C=CC=CC=2)=C1 RAYLNUXJFMKJSI-UHFFFAOYSA-N 0.000 description 1
- KFPFBVPGGFIZMH-UHFFFAOYSA-N n-benzyl-3-hydroxy-5-methoxy-n-phenylbenzenesulfonamide Chemical compound COC1=CC(O)=CC(S(=O)(=O)N(CC=2C=CC=CC=2)C=2C=CC=CC=2)=C1 KFPFBVPGGFIZMH-UHFFFAOYSA-N 0.000 description 1
- UKZGRUKCCPRBQT-UHFFFAOYSA-N n-benzyl-3-methoxy-5-nitro-n-phenylbenzenesulfonamide Chemical compound COC1=CC([N+]([O-])=O)=CC(S(=O)(=O)N(CC=2C=CC=CC=2)C=2C=CC=CC=2)=C1 UKZGRUKCCPRBQT-UHFFFAOYSA-N 0.000 description 1
- ZNLBVBNGNVJDHL-UHFFFAOYSA-N n-benzyl-n-(3,5-dinitrophenyl)benzenesulfonamide Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC(N(CC=2C=CC=CC=2)S(=O)(=O)C=2C=CC=CC=2)=C1 ZNLBVBNGNVJDHL-UHFFFAOYSA-N 0.000 description 1
- VFCHAEOHQONBRX-UHFFFAOYSA-N n-benzyl-n-(3-chloro-5-hydroxyphenyl)benzenesulfonamide Chemical compound OC1=CC(Cl)=CC(N(CC=2C=CC=CC=2)S(=O)(=O)C=2C=CC=CC=2)=C1 VFCHAEOHQONBRX-UHFFFAOYSA-N 0.000 description 1
- FGJZKXRSHGFYPU-UHFFFAOYSA-N n-benzyl-n-(3-chloro-5-nitrophenyl)benzenesulfonamide Chemical compound [O-][N+](=O)C1=CC(Cl)=CC(N(CC=2C=CC=CC=2)S(=O)(=O)C=2C=CC=CC=2)=C1 FGJZKXRSHGFYPU-UHFFFAOYSA-N 0.000 description 1
- JLNQSSCDJBUQAX-UHFFFAOYSA-N n-benzyl-n-(3-methyl-5-nitrophenyl)benzenesulfonamide Chemical compound [O-][N+](=O)C1=CC(C)=CC(N(CC=2C=CC=CC=2)S(=O)(=O)C=2C=CC=CC=2)=C1 JLNQSSCDJBUQAX-UHFFFAOYSA-N 0.000 description 1
- HHMLTTJOPJHQDC-UHFFFAOYSA-N n-benzyl-n-phenyl-3-[2-(pyridin-4-ylamino)ethoxy]benzenesulfonamide Chemical compound C=1C=CC(OCCNC=2C=CN=CC=2)=CC=1S(=O)(=O)N(C=1C=CC=CC=1)CC1=CC=CC=C1 HHMLTTJOPJHQDC-UHFFFAOYSA-N 0.000 description 1
- JJPQGMODQRRKOU-UHFFFAOYSA-N n-methyl-3,5-dinitro-n-phenylbenzenesulfonamide Chemical compound C=1C([N+]([O-])=O)=CC([N+]([O-])=O)=CC=1S(=O)(=O)N(C)C1=CC=CC=C1 JJPQGMODQRRKOU-UHFFFAOYSA-N 0.000 description 1
- WPUFYGUABBUGTD-UHFFFAOYSA-N n-methyl-n-pyridin-2-yl-3-[2-(pyridin-4-ylamino)ethoxy]benzenesulfonamide Chemical compound C=1C=CC(OCCNC=2C=CN=CC=2)=CC=1S(=O)(=O)N(C)C1=CC=CC=N1 WPUFYGUABBUGTD-UHFFFAOYSA-N 0.000 description 1
- LSCYTCMNCWMCQE-UHFFFAOYSA-N n-methylpyridin-4-amine Chemical compound CNC1=CC=NC=C1 LSCYTCMNCWMCQE-UHFFFAOYSA-N 0.000 description 1
- PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 1
- WHKQNGPIKIPFRF-UHFFFAOYSA-N n-pyridin-4-yl-2-[3-(thiophen-2-ylsulfonylamino)anilino]acetamide Chemical compound C=1C=NC=CC=1NC(=O)CNC(C=1)=CC=CC=1NS(=O)(=O)C1=CC=CS1 WHKQNGPIKIPFRF-UHFFFAOYSA-N 0.000 description 1
- SPGPFRMDMGBRPT-UHFFFAOYSA-N n-pyridin-4-yl-2-[3-[[3-(trifluoromethyl)phenyl]sulfonylamino]phenoxy]acetamide Chemical compound FC(F)(F)C1=CC=CC(S(=O)(=O)NC=2C=C(OCC(=O)NC=3C=CN=CC=3)C=CC=2)=C1 SPGPFRMDMGBRPT-UHFFFAOYSA-N 0.000 description 1
- ZFIFHAKCBWOSRN-UHFFFAOYSA-N naphthalene-1-sulfonamide Chemical compound C1=CC=C2C(S(=O)(=O)N)=CC=CC2=C1 ZFIFHAKCBWOSRN-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical group C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000007344 nucleophilic reaction Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 125000005544 phthalimido group Chemical group 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- CDRNYKLYADJTMN-UHFFFAOYSA-N pyridine-3-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CN=C1 CDRNYKLYADJTMN-UHFFFAOYSA-N 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 125000005624 silicic acid group Chemical class 0.000 description 1
- 238000006884 silylation reaction Methods 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- RNVYQYLELCKWAN-UHFFFAOYSA-N solketal Chemical compound CC1(C)OCC(CO)O1 RNVYQYLELCKWAN-UHFFFAOYSA-N 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000004291 sulphur dioxide Substances 0.000 description 1
- 235000010269 sulphur dioxide Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical class C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- HNKJADCVZUBCPG-UHFFFAOYSA-N thioanisole Chemical compound CSC1=CC=CC=C1 HNKJADCVZUBCPG-UHFFFAOYSA-N 0.000 description 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 125000005424 tosyloxy group Chemical group S(=O)(=O)(C1=CC=C(C)C=C1)O* 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- PVFOMCVHYWHZJE-UHFFFAOYSA-N trichloroacetyl chloride Chemical compound ClC(=O)C(Cl)(Cl)Cl PVFOMCVHYWHZJE-UHFFFAOYSA-N 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4306506A DE4306506A1 (de) | 1993-03-03 | 1993-03-03 | Neue 4-Alkylaminopyridine - Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
DEP4306506.6 | 1993-03-03 | ||
USP4312966.8 | 1993-04-21 | ||
DE19934312966 DE4312966A1 (de) | 1993-04-21 | 1993-04-21 | Neue 4-Aminopyridine - Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2156729A1 true CA2156729A1 (en) | 1994-09-15 |
Family
ID=25923593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002156729A Abandoned CA2156729A1 (en) | 1993-03-03 | 1994-03-02 | New 4-aminopyridines, processes for their production as well as pharmaceutical agents containing these compounds |
Country Status (22)
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6962905B1 (en) | 1999-04-21 | 2005-11-08 | Astrazeneca Ab | Pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug |
US8258138B2 (en) | 2008-08-29 | 2012-09-04 | Xention Limited | Potassium channel blockers |
US8372840B2 (en) | 2008-08-29 | 2013-02-12 | Xention Limited | Potassium channel blockers |
US8673901B2 (en) | 2008-08-29 | 2014-03-18 | Xention Limited | Potassium channel blockers |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4430755A1 (de) * | 1994-08-30 | 1996-03-07 | Boehringer Mannheim Gmbh | Neue Phosphanoxide, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
US5792769A (en) * | 1995-09-29 | 1998-08-11 | 3-Dimensional Pharmaceuticals, Inc. | Guanidino protease inhibitors |
GB9525620D0 (en) * | 1995-12-15 | 1996-02-14 | Glaxo Group Ltd | Chemical compounds |
ATE260112T1 (de) | 1995-12-29 | 2004-03-15 | Dimensional Pharm Inc | Amidino proteaseinhibitoren |
GB9602166D0 (en) | 1996-02-02 | 1996-04-03 | Zeneca Ltd | Aminoheterocyclic derivatives |
EP0880501A1 (en) | 1996-02-02 | 1998-12-02 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
SE9602646D0 (sv) * | 1996-07-04 | 1996-07-04 | Astra Ab | Pharmaceutically-useful compounds |
CN1228087A (zh) * | 1996-08-14 | 1999-09-08 | 曾尼卡有限公司 | 取代的嘧啶衍生物和它们的药物用途 |
JP2001500864A (ja) * | 1996-09-13 | 2001-01-23 | メルク エンド カンパニー インコーポレーテッド | トロンビン阻害物質 |
GB9821483D0 (en) | 1998-10-03 | 1998-11-25 | Glaxo Group Ltd | Chemical compounds |
UA56197C2 (uk) | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
TW499412B (en) | 1996-11-26 | 2002-08-21 | Dimensional Pharm Inc | Aminoguanidines and alkoxyguanidines as protease inhibitors |
US6127191A (en) * | 1996-12-03 | 2000-10-03 | 3-Dimensional Pharmaceuticals, Inc. | Aminobenzenedicarboxylic acid-based combinatorial libraries |
ATE242774T1 (de) | 1997-02-13 | 2003-06-15 | Astrazeneca Ab | Heterozyklische verbindungen die als oxido- squalen-zyklase-inhibitoren anwendung finden |
WO1998035956A1 (en) | 1997-02-13 | 1998-08-20 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
GB9715895D0 (en) | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic compounds |
JP4327915B2 (ja) * | 1998-03-30 | 2009-09-09 | 株式会社デ・ウエスタン・セラピテクス研究所 | スルフォンアミド誘導体 |
CN1173950C (zh) | 1998-10-06 | 2004-11-03 | 大日本制药株式会社 | 2,3-二取代的吡啶衍生物、其制备方法、含有其的药物组合物和用于制备中的中间体 |
GB9902989D0 (en) | 1999-02-11 | 1999-03-31 | Zeneca Ltd | Heterocyclic derivatives |
WO2002012207A1 (en) | 2000-08-04 | 2002-02-14 | 3-Dimensional Pharmaceuticals, Inc. | Cyclic oxyguanidine protease inhibitors |
TWI303628B (en) * | 2000-10-04 | 2008-12-01 | Kissei Pharmaceutical | 5-amidino-2-hydroxybenienesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
WO2002089740A2 (en) * | 2001-05-07 | 2002-11-14 | Smithkline Beecham Corporation | Sulfonamides |
EP1399137A4 (en) * | 2001-05-07 | 2005-12-14 | Smithkline Beecham Corp | SULPHONAMIDES |
US7476683B2 (en) | 2002-08-27 | 2009-01-13 | Merck Patent Gmbh | Glycinamide derivatives as raf-kinase inhibitors |
AU2003263402A1 (en) | 2002-09-20 | 2004-04-08 | Pfizer Products Inc. | Amide and sulfonamide ligands for the estrogen receptor |
CA2543249C (en) | 2003-11-05 | 2012-08-07 | F. Hoffmann-La Roche Ag | Phenyl derivatives as ppar agonists |
EP2125735B1 (en) * | 2007-02-28 | 2012-06-27 | Advinus Therapeutics Private Limited | 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application |
RU2353619C2 (ru) * | 2007-06-28 | 2009-04-27 | Общество С Ограниченной Ответственностью "Бионика" | Новые соединения, обладающие функцией антикоагулянтов, фармацевтические композиции на их основе для лечения тромботических состояний и плазмозамещающий раствор для коррекции гиперкоагуляционных нарушений при гемодилюции |
RU2354647C2 (ru) * | 2007-06-28 | 2009-05-10 | Общество С Ограниченной Ответственностью "Бионика" | Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе |
US8265575B2 (en) * | 2009-06-16 | 2012-09-11 | Mediatek Inc. | Methods for handling a transmitting process and communication apparatuses utilizing the same |
US8207639B2 (en) | 2009-10-23 | 2012-06-26 | Sunonwealth Electric Machine Industry Co., Ltd. | Motor and heating dissipating fan including motor having an annular balancing member |
RU2685261C1 (ru) * | 2018-04-05 | 2019-04-17 | Общество с ограниченной ответственностью "ФК ЛАБОРАТОРИЗ" | Вещество 4-амино-1-{ 2-[3-метил-5-(бензолсульфонилокси)фенокси] этил} -пиридиний хлорид, обладающее свойствами биологически активного агента, влияющими на естественно текущие процессы свертываемости крови млекопитающих, антикоагулянт на его основе и способ его получения путем химического синтеза |
CN109172573B (zh) * | 2018-09-12 | 2021-01-26 | 黑龙江中桂制药有限公司 | 一种口服抗血栓药物及其用途 |
CN110669337B (zh) * | 2019-07-08 | 2020-09-25 | 中国科学院长春应用化学研究所 | 一种芳香型二胺单体及其制备方法 |
WO2024243343A2 (en) * | 2023-05-23 | 2024-11-28 | John Karanicolas | Compounds that re-activate mutant p53 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1097620A1 (ru) * | 1983-02-16 | 1984-06-15 | Новокузнецкий научно-исследовательский химико-фармацевтический институт | Способ получени диэтил-N-(6-метилпиридил-2)-аминометиленмалоната |
SU1318599A1 (ru) * | 1985-06-26 | 1987-06-23 | МГУ им.М.В.Ломоносова | Способ получени 1-алкил-2-хлор-2-алкоксиэтенилалкил(арил)хлорфосфинов |
DE3529529A1 (de) * | 1985-08-17 | 1987-02-19 | Boehringer Mannheim Gmbh | Verfahren zur herstellung einer stabilen modifikation von torasemid |
GB8819307D0 (en) * | 1988-08-13 | 1988-09-14 | Pfizer Ltd | Antiarrhythmic agents |
JPH0256465A (ja) * | 1988-08-22 | 1990-02-26 | Hamari Yakuhin Kogyo Kk | アセトアミド化合物 |
US4885927A (en) * | 1988-09-12 | 1989-12-12 | General Motors Corporation | Method and apparatus for press forming intricate metallic shapes such as spool valve elements |
EP0610432A1 (en) * | 1991-10-31 | 1994-08-17 | Smithkline Beecham Corporation | C8-cyclic peptidomimetics as fibrinogen antagonists |
TW221996B (enrdf_load_stackoverflow) * | 1991-11-14 | 1994-04-01 | Glaxo Group Ltd | |
DE4212304A1 (de) * | 1992-04-13 | 1993-10-14 | Cassella Ag | Asparaginsäurederivate, ihre Herstellung und Verwendung |
-
1994
- 1994-02-22 TW TW083101504A patent/TW257757B/zh active
- 1994-02-28 IL IL10878694A patent/IL108786A/en not_active IP Right Cessation
- 1994-03-02 RU RU95122612A patent/RU2126388C1/ru active
- 1994-03-02 SK SK1082-95A patent/SK108295A3/sk unknown
- 1994-03-02 NZ NZ262725A patent/NZ262725A/en unknown
- 1994-03-02 KR KR1019950703694A patent/KR100252551B1/ko not_active Expired - Fee Related
- 1994-03-02 DK DK94909909T patent/DK0687253T3/da active
- 1994-03-02 AT AT94909909T patent/ATE174590T1/de not_active IP Right Cessation
- 1994-03-02 JP JP6519556A patent/JPH08507503A/ja active Pending
- 1994-03-02 CN CN94191554A patent/CN1046710C/zh not_active Expired - Fee Related
- 1994-03-02 DE DE59407494T patent/DE59407494D1/de not_active Expired - Fee Related
- 1994-03-02 FI FI954105A patent/FI954105A7/fi unknown
- 1994-03-02 CA CA002156729A patent/CA2156729A1/en not_active Abandoned
- 1994-03-02 CZ CZ952254A patent/CZ225495A3/cs unknown
- 1994-03-02 AU AU62574/94A patent/AU682026B2/en not_active Ceased
- 1994-03-02 EP EP94909909A patent/EP0687253B1/de not_active Expired - Lifetime
- 1994-03-02 WO PCT/EP1994/000608 patent/WO1994020467A1/de not_active Application Discontinuation
- 1994-03-02 ES ES94909909T patent/ES2127919T3/es not_active Expired - Lifetime
- 1994-03-02 PL PL94310520A patent/PL176455B1/pl unknown
- 1994-03-02 HU HU9502568A patent/HUT72898A/hu unknown
-
1995
- 1995-09-01 NO NO953447A patent/NO953447D0/no unknown
-
1999
- 1999-03-16 GR GR990400775T patent/GR3029691T3/el unknown
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6962905B1 (en) | 1999-04-21 | 2005-11-08 | Astrazeneca Ab | Pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug |
US8258138B2 (en) | 2008-08-29 | 2012-09-04 | Xention Limited | Potassium channel blockers |
US8372840B2 (en) | 2008-08-29 | 2013-02-12 | Xention Limited | Potassium channel blockers |
US8673901B2 (en) | 2008-08-29 | 2014-03-18 | Xention Limited | Potassium channel blockers |
US9073834B2 (en) | 2008-08-29 | 2015-07-07 | Xention Limited | Potassium channel blockers |
Also Published As
Publication number | Publication date |
---|---|
RU2126388C1 (ru) | 1999-02-20 |
EP0687253B1 (de) | 1998-12-16 |
FI954105A0 (fi) | 1995-09-01 |
PL310520A1 (en) | 1995-12-27 |
DE59407494D1 (de) | 1999-01-28 |
NO953447L (no) | 1995-09-01 |
DK0687253T3 (da) | 1999-08-23 |
KR100252551B1 (ko) | 2000-05-01 |
IL108786A0 (en) | 1994-06-24 |
NO953447D0 (no) | 1995-09-01 |
CN1119858A (zh) | 1996-04-03 |
PL176455B1 (pl) | 1999-05-31 |
HU9502568D0 (en) | 1995-11-28 |
CN1046710C (zh) | 1999-11-24 |
NZ262725A (en) | 1997-05-26 |
EP0687253A1 (de) | 1995-12-20 |
WO1994020467A1 (de) | 1994-09-15 |
CZ225495A3 (en) | 1996-01-17 |
HUT72898A (en) | 1996-06-28 |
KR960701019A (ko) | 1996-02-24 |
ES2127919T3 (es) | 1999-05-01 |
AU6257494A (en) | 1994-09-26 |
FI954105A7 (fi) | 1995-09-01 |
ATE174590T1 (de) | 1999-01-15 |
SK108295A3 (en) | 1996-06-05 |
AU682026B2 (en) | 1997-09-18 |
IL108786A (en) | 1999-04-11 |
TW257757B (enrdf_load_stackoverflow) | 1995-09-21 |
GR3029691T3 (en) | 1999-06-30 |
JPH08507503A (ja) | 1996-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2156729A1 (en) | New 4-aminopyridines, processes for their production as well as pharmaceutical agents containing these compounds | |
EP1307444B1 (en) | Substituted heterocyclic amides | |
KR101258504B1 (ko) | 히스톤 데아세틸라제의 억제제 | |
AU776344B2 (en) | Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands | |
US6162821A (en) | Preparation and use of ortho-sulfonamide heteroarly hydroxamic acids as matrix metalloproteinase and TACE inhibitors | |
CZ187397A3 (en) | Derivative of arylsulfonamide and heteroarylsulfonamide, process of its preparation and use | |
KR20000022437A (ko) | 신규 아미디노 유도체 및 트롬빈 억제제로서의 그의 용도 | |
EP2116530A1 (en) | Novel pyrrole derivative having ureide group and aminocarbonyl group as substituents | |
CA2299286A1 (en) | Bicyclic compounds as ligands for 5-ht1 receptors | |
WO2006063113A2 (en) | Ureas as factor xa inhibitors | |
US5795892A (en) | 4-aminopyridazines, method of preparing them and drugs containing these compounds | |
CA2157215A1 (en) | New 4-aminopyridines - processes for their production as well as pharmaceutical agents containing them | |
EP1678161A2 (en) | Thioether-substituted benzamides as inhibitors of factor xa | |
CA2621390A1 (en) | Iminooxazolidine derivatives and use thereof | |
WO2006055951A2 (en) | Tetrahydroisoquinolines as factor xa inhibitors | |
DE4306506A1 (de) | Neue 4-Alkylaminopyridine - Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
MXPA06006858A (es) | Tetrahidrobenzacepinas y su uso en la modulacion del receptor d3 de la dopamina. | |
US5824679A (en) | Phosphanoxides--preparation and use | |
US5942544A (en) | α-branched anilines, toluenes, and analogs thereof as factor Xa inhibitors | |
WO2006063293A2 (en) | THIOUREAS AS FACTOR Xa INHIBITORS | |
MXPA99003526A (en) | The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors | |
MXPA00006424A (en) | Metalloprotease inhibitors, process for their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |